2022-12-15T11:02:08-06:00 2022-06-30 366055558 GRANT THORNTON LLP 171 N CLARK ST SUITE 200 CHICAGO IL 60601 990 2021-07-01 133039601 ALZHEIMER'S DISEASE & RELATED DISORDERS ASSOCIATION INC ALZH 3123358700 225 N MICHIGAN AVE 17TH FLOOR CHICAGO IL 606017633 RICHARD HOVLAND COO, CFO, & ASST. TREASURER 2026388660 2022-12-15 1 RICHARD HOVLAND XXX-XX-XXXX BRIDGET ROCHE P00666837 3128560200 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z ALZHEIMER'S ASSOCIATION RICHARD HOVLAND 225 N MICHIGAN AVE 17TH FLOOR CHICAGO IL 606017633 798177427 0 X WWW.ALZ.ORG X 1980 DE THE ALZHEIMER'S ASSOCIATION LEADS THE WAY TO END ALZHEIMER'S AND ALL (CONTINUED IN SCHEDULE O) OTHER DEMENTIA - BY ACCELERATING GLOBAL RESEARCH, DRIVING RISK REDUCTION AND EARLY DETECTION, AND MAXIMIZING QUALITY CARE AND SUPPORT. 29 29 2276 58757 0 0 377428810 460358014 3318234 2990858 16168267 41932447 7611330 -3242741 404526641 502038578 66455349 84842289 0 0 181604398 199012012 1642050 2093518 78572771 115849579 157226680 365551376 443174499 38975265 58864079 497643896 493034630 142547117 173166662 355096779 319867968 X THE ALZHEIMER'S ASSOCIATION LEADS THE WAY TO END ALZHEIMER'S AND ALL OTHER DEMENTIA - BY ACCELERATING GLOBAL RESEARCH, DRIVING RISK REDUCTION (MISSION CONTINUED IN SCHEDULE O) 0 0 231581442 4703735 1739096 SEE SCHEDULE OPUBLIC AWARENESS AND EDUCATION - ALZHEIMER'S IS A PROGRESSIVE, DEGENERATIVE AND ULTIMATELY FATAL DISEASE. TOO FEW AMERICANS UNDERSTAND THE CURRENT AND FUTURE ECONOMIC IMPACT OF ALZHEIMER'S. ALREADY MORE THAN 6 MILLION AMERICANS ARE LIVING WITH ALZHEIMER'S AND AS MANY AS 11 MILLION PEOPLE ARE PROVIDING UNPAID CARE AND SUPPORT. AND THIS MASSIVE GROUP IS IN NEED OF INFORMATION AND RESOURCES.THE ALZHEIMER'S ASSOCIATION HAS INVESTED IN EDUCATION CAMPAIGNS AND INITIATIVES TO INCREASE CONCERN ABOUT ALZHEIMER'S DISEASE AND AWARENESS OF THE ALZHEIMER'S ASSOCIATION COMMUNICATING OUR ROLE AS LEADERS OF THE CAUSE. KEY MESSAGES INCLUDE THE IMPORTANCE OF EARLY DETECTION, RESOURCES FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND THE SOCIETAL IMPACT OF THE DISEASE. MILLIONS OF CONSTITUENTS PARTICIPATED IN OUR PROGRAMS IN LOCAL COMMUNITIES AND ON-LINE.PATIENT AND FAMILY SERVICES - THE ALZHEIMER'S ASSOCIATION* PROVIDES AN ARRAY OF INFORMATION AND SUPPORT SERVICES DESIGNED SPECIFICALLY FOR INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES, FRIENDS AND CAREGIVERS. IN ORDER TO MEET THE DIVERSE NEEDS OF INDIVIDUALS AFFECTED BY ALZHEIMER'S DISEASE, THE ASSOCIATION'S PROGRAMS AND SERVICES ARE OFFERED IN PERSON, BY PHONE AND ONLINE. IN CHAPTERS THROUGHOUT THE COUNTRY, CONSTITUENTS CAN ATTEND EDUCATION PROGRAMS AND SUPPORT GROUPS, RECEIVE PERSONALIZED CARE CONSULTATION, ENGAGE IN EARLY STAGE PROGRAMS, AND ENROLL IN SUPPORT PROGRAMS. IN ORDER TO MEET THE NEEDS OF CONSTITUENTS WHO RELY ON THE WEB FOR INFORMATION AND SUPPORT, THE ASSOCIATION OFFERS A ROBUST CAREGIVER CENTER. WITHIN THE CAREGIVER CENTER, FAMILIES AND CAREGIVERS CAN ACCESS ALZHEIMER'S NAVIGATOR*, AN INNOVATIVE TOOL TO HELP CAREGIVERS AND PEOPLE WITH DEMENTIA EVALUATE THEIR NEEDS, CREATE A CUSTOMIZED ACTION PLAN AND LINK TO INFORMATION, SUPPORT AND LOCAL RESOURCES FOR INDIVIDUALS LIVING WITH ALZHEIMER'S. ALSO AVAILABLE THROUGH THE CAREGIVER CENTER, FOR INDIVIDUALS LOOKING FOR SUPPORT FROM OTHERS LIVING IN SIMILAR SITUATIONS IS ALZCONNECTED*, AN ON-LINE COMMUNITY THAT INCLUDES MULTIPLE FORUMS FOR DIVERSE AUDIENCES.THROUGH THE ASSOCIATION'S HELPLINE, AVAILABLE 24 HOURS A DAY, 7 DAYS A WEEK, 365 DAYS A YEAR, INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES AND CAREGIVERS CAN TALK TO A SPECIALIST TO RECEIVE INFORMATION AND BASIC EDUCATION ABOUT THE DISEASE; AND GUIDANCE FOR MORE COMPLICATED OR URGENT SITUATIONS, WITH MASTERS-LEVEL COUNSELORS WHO ARE AVAILABLE TO CONSTITUENTS, ANY TIME, DAY OR NIGHT. ADDITIONALLY, CALLS CAN BE HANDLED IN OVER 170 DIFFERENT LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE. ANNUALLY, THE HELPLINE RECEIVES APPROXIMATELY 250,000 CALLS.THE ASSOCIATION'S WEBSITE (WWW.ALZ.ORG*) RECEIVES MORE THAN 32 MILLION VISITS A YEAR. ONLINE PROGRAMS INCLUDE: SELF-SERVICE EDUCATION PROGRAMS, AN ONLINE COMMUNITY, AN INTERACTIVE BRAIN TOUR (AVAILABLE IN 15 LANGUAGES), ACCESS TO COMPREHENSIVE DISEASE INFORMATION, PORTALS IN SPANISH, CHINESE, VIETNAMESE, JAPANESE, AND KOREAN; A VIRTUAL LIBRARY, A SAFETY CENTER, AND A SECTION DEVELOPED SPECIFICALLY FOR PEOPLE LIVING WITH ALZHEIMER'S, WITH INPUT FROM PEOPLE IN THE EARLY STAGES OF ALZHEIMER'S DISEASE AND THEIR CARE PARTNERS. THROUGH THE ASSOCIATION'S EARLY STAGE INITIATIVE, INDIVIDUALS IN THE EARLY STAGES OF THE DISEASE CAN PARTICIPATE IN EDUCATION PROGRAMS, SUPPORT GROUPS AND SOCIAL ENGAGEMENT PROGRAMS. ADDITIONALLY, THE ASSOCIATION CONVENES AN EARLY STAGE ADVISORY GROUP WHOSE MEMBERS RAISE AWARENESS, ADVOCATE FOR THE CAUSE, AND PROVIDE GUIDANCE AND REVIEW OF PROGRAMS AND SERVICES.THE ALZHEIMER'S ASSOCIATION LAUNCHED AN INITIATIVE TO WORK WITH HEALTH SYSTEMS, LONG-TERM CARE FACILITIES, AND COMMUNITY-BASED DEMENTIA PROVIDERS WITH EVIDENCE-BASED INFORMATION AND QUALITY IMPROVEMENT PROGRAMMING TO ENHANCE HOW THESE SYSTEMS PROVIDE CARE AND SUPPORT SERVICES. UNIQUE PROGRAMMING OPPORTUNITIES INCLUDE DIRECT TRAINING TO PROVIDERS AND VIDEO-BASED EDUCATION THROUGH PROJECT ECHO. THE PROGRAMS AND SERVICES OF THE ALZHEIMER'S ASSOCIATION ARE DESIGNED TO PROVIDE EDUCATION, INFORMATION, SUPPORT, AND RESOURCES IN ORDER TO HELP INDIVIDUALS WITH ALZHEIMER'S, THEIR FAMILIES AND CAREGIVERS NAVIGATE THE LONG AND COMPLICATED JOURNEY THROUGH ALZHEIMER'S DISEASE AND OTHER DEMENTIAS.* THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. 88279300 70119525 1251762 SEE SCHEDULE ORESEARCH - THE ALZHEIMER'S ASSOCIATION IS ON THE FOREFRONT OF THE ALZHEIMER'S SCIENTIFIC FIELD, GLOBALLY CONNECTING RESEARCHERS IN THE QUEST TO FIND METHODS OF TREATMENT, PREVENTION AND A CURE. THE ALZHEIMER'S ASSOCIATION IMPLEMENTS AN AGGRESSIVE GLOBAL RESEARCH AND SCIENCE PROGRAM STRATEGICALLY DESIGNED TO ACCELERATE PROGRESS BY FOSTERING INNOVATION, IDENTIFYING AND CLOSING CRITICAL KNOWLEDGE GAPS, DEVELOPING AND DISSEMINATING TOOLS, AND NURTURING SCIENTIFIC TALENT.THE ALZHEIMER'S ASSOCIATION HAS BEEN A CATALYST AND CONVENER FOR MORE THAN 30 YEARS. WHETHER FUNDING INNOVATIVE GRANTS TO HELP FURTHER TREATMENTS AND DISCOVERY, HOSTING THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE* (AAIC*), THE WORLD'S LARGEST GATHERING OF ALZHEIMER'S RESEARCHERS, OR LEADING ENDEAVORS LIKE THE WORLDWIDE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (WW-ADNI) TO ACCELERATE ADVANCES IN IMAGING, THE ALZHEIMER'S ASSOCIATION SEEKS TO FUND AND ADVANCE BEST-IN-CLASS RESEARCH AND WORKS WITH COLLABORATORS AROUND THE GLOBE FROM ALL SECTORS TO HASTEN THIS PROGRESS.* THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. 25861452 10019029 0 SEE SCHEDULE OADVOCACY - AS ALZHEIMER'S DISEASE THREATENS TO BANKRUPT FAMILIES, BUSINESSES AND OUR HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR BETTER CARE AND RESOURCES, AND HEALTH AND LONG-TERM COVERAGE TO ENSURE HIGH QUALITY COST EFFECTIVE CARE FOR PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR FAMILIES. MORE THAN 600,000 GRASS ROOTS ALZHEIMER'S ASSOCIATION ADVOCATES SPEAK UP FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND ENCOURAGE CONGRESS TO INCREASE FUNDING FOR RESEARCH AND CARE. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES.BEGINNING IN TAX YEAR 2021, THE PREVIOUSLY SEPARATE CHAPTER SERVICE PROGRAM IS NOW BEING INCORPORATED INTO THE VARIOUS OTHER PROGRAMS OF THE ALZHEIMER'S ASSOCIATION ON THE AUDITED FINANCIAL STATEMENTS AND IS NO LONGER REFLECTED AS A STANDALONE PROGRAM. 345722194 1 1 0 1 0 0 0 0 0 1 1 1 0 0 1 1 0 1 0 0 1 1 0 1 1 1 0 1 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 1 1 1 1 0 1 1035 0 1 2276 1 0 0 0 0 0 1 1 0 0 0 0 1 0 X 29 29 0 0 1 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X X RICHARD HOVLAND COO CFO & ASST TREASURER 3123355771 225 N MICHIGAN AVE 17TH FLOOR CHICAGO IL 606017633 BRIAN RICHARDSON CHAIR AND DIRECTOR 12.00 0.50 X X 0 0 0 SARAH LORANCE - CHAIR ELECT AND DIRECTOR (AS OF 10/2021) 12.00 0.00 X X 0 0 0 CECILE PERICH VICE CHAIR AND DIRECTOR 12.00 0.00 X X 0 0 0 RYAN MUNDY SECRETARY AND DIRECTOR 10.00 0.00 X X 0 0 0 BRUCE BAUDE TREASURER (AS OF 10/2021)/DIRECTOR 10.00 0.00 X X 0 0 0 JULIA WALLACE TREASURER (THRU 10/2021)/DIRECTOR 10.00 0.00 X X 0 0 0 ALEX TSAO DIRECTOR 5.00 0.00 X 0 0 0 ANDREW DAHLKEMPER DIRECTOR 5.00 0.00 X 0 0 0 ARTHENA CASTON DIRECTOR 5.00 0.00 X 0 0 0 BRUCE LAMB DIRECTOR 5.00 0.00 X 0 0 0 DAVID GONZALES DIRECTOR 5.00 0.00 X 0 0 0 DAVID HUNTER DIRECTOR 5.00 0.00 X 0 0 0 DEAN BRENNER DIRECTOR 5.00 0.00 X 0 0 0 DEBRA PIERSON DIRECTOR 5.00 0.00 X 0 0 0 DEREK VAN AMERONGEN DIRECTOR 5.00 0.00 X 0 0 0 DOZENE GUISHARD DIRECTOR (AS OF 10/2021) 5.00 0.00 X 0 0 0 EILEEN KAMERICK DIRECTOR 5.00 0.00 X 0 0 0 ELIZABETH SHIH DIRECTOR (AS OF 10/2021) 5.00 0.00 X 0 0 0 GEOFF HEREDIA DIRECTOR 5.00 0.00 X 0 0 0 GEORGE JOHNSON DIRECTOR 5.00 0.00 X 0 0 0 GEORGE WALZ DIRECTOR 5.00 0.00 X 0 0 0 HELEN BROOKS DIRECTOR (THRU 02/2022) 5.00 0.00 X 0 0 0 IRENE SUDAC DIRECTOR 5.00 0.00 X 0 0 0 JAMES GROSSMANN DIRECTOR (THRU 10/2021) 5.00 0.00 X 0 0 0 JAY REINSTEIN DIRECTOR (THRU 10/2021) 5.00 0.00 X 0 0 0 JOE ARCINIEGA DIRECTOR 5.00 0.00 X 0 0 0 JOSEPH JOE MONTMINY DIRECTOR (AS OF 10/2021) 5.00 0.00 X 0 0 0 KAREN STEVENSON DIRECTOR 5.00 0.00 X 0 0 0 KARYNE JONES DIRECTOR 5.00 0.00 X 0 0 0 MINOO JAVANMARDIAN DIRECTOR 5.00 0.00 X 0 0 0 NICOLE WALKER DIRECTOR 5.00 0.00 X 0 0 0 WILLIAM THOMAS DIRECTOR 5.00 0.00 X 0 0 0 HARRY JOHNS PRESIDENT (THRU 11/2021)/CEO 60.00 0.79 X 1215907 22318 229909 KATHERINE JOANNE PIKE CSO/PRESIDENT (AS OF 11/2021) 60.00 0.13 X 725216 2286 105087 RICHARD HOVLAND COO, CFO, & ASST. TREASURER 60.00 0.04 X 648514 632 96745 CHRISTINE FOH - ASST SECY VP LEGAL & GC (THRU 11/2021) 60.00 0.04 X 374236 0 22013 ANTHONY D'AMATO - ASST SECY & VP LEGAL & GC (AS OF 11/2021) 60.00 0.00 X 43288 0 3368 DONNA MCCULLOUGH - CHIEF MISSION & FIELD OPERATIONS OFFICER 60.00 0.02 X 692855 328 81992 MARIA CARRILLO CHIEF SCIENCE OFFICER 60.00 0.00 X 609879 0 100502 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 60.00 1.10 X 559973 16233 96812 GLENDA BERRY WEST AREA LEADER 60.00 0.00 X 502772 0 83195 KENANN CASSIDY EAST AREA LEADER 60.00 0.00 X 507599 0 75308 MICHELLE HELTON - FORMER CFO (THRU 5/21)/ VP, FINANCIAL OPS. 60.00 0.00 X 414509 0 67632 6294748 41797 962563 340 1 1 0 NAVISTAR DIRECT MARKETING LLC 4612 NAVISTAR DRIVE FREDERICK MD 21703 DIRECT MARKETING 15166849 HAWORTH MARKETING & MEDIA LLC 45 S 7TH STREET SUITE 2400 MINNEAPOLIS MN 55402 ADVERTISING 14351817 NEVER WITHOUT LLC 580 TANACREST ATLANTA GA 30328 ADVERTISING 9128371 PERSONIFY INC 6500 RIVER PLACE BOULEVARD BLD 3 SU AUSTIN TX 78730 CRM/TECHNOLOGY 4313260 BLACKBAUD INC PO BOX 930256 ATLANTA GA 31193 CRM/TECHNOLOGY 3012559 115 591907 22627321 26875400 410263386 22715625 460358014 SAFE RETURN REG. FEES 611710 1450030 1450030 PROGRAM CONFERENCES 611710 964998 964998 JOURNAL 511120 398163 398163 CAREGIVER TRAINING 611710 177667 177667 2990858 12686126 12686126 82315 82315 316274095 286939465 88309 29334630 -88309 29246321 29246321 3935242 22627321 9036137 -5100895 -5100895 24675 19263 5412 5412 99420 55675 43745 43745 STATE SPONSORED REV 900099 1363724 1363724 MISCELLANEOUS REVENUE 900099 334434 334434 AFFILIATE REVENUE 900099 28524 28524 1726682 502038578 2990858 0 38689706 67256372 67256372 1839936 1839936 15745981 15745981 3548230 1822710 1426137 299383 544640 201266 343374 149270002 111886340 3796089 33587573 13225035 9774958 439500 3010577 21749776 15872152 987884 4889740 10674329 7913960 413629 2346740 1682345 999456 461665 221224 172697 172697 736281 736281 2093518 2093518 269717 269717 36736068 26850119 1945480 7940469 34335765 30966570 36208 3332987 41808429 27921245 4905755 8981429 3681379 2759804 439064 482511 15977253 10985285 2679457 2312511 5334489 3742944 106296 1485249 12000676 5350979 154628 6495069 3268335 2222957 487785 557593 750047 515072 128112 106863 VOLUNTEER EXPENSES 245702 192220 2868 50614 227497 165587 26563 35347 443174499 345722194 18879534 78572771 X 20713830 11403025 3305160 6005645 25880339 33251956 70423217 65618284 7915070 7842339 1515699 994394 6281152 7884837 49516141 26468343 21107254 23047798 324420496 307441707 39279061 46162297 821608 791018 497643896 493034630 33248833 42837349 93002734 113363842 3481887 3137654 12813663 13827817 142547117 173166662 X 211697101 182693824 143399678 137174144 355096779 319867968 497643896 493034630 X 58864079 -89598366 -5 -4494519 X 0 1 X 1 1 1 X 319867489 361019360 377982664 375847517 460358014 1895075044 319867489 361019360 377982664 375847517 460358014 1895075044 21388917 1873686127 6355626 8237819 8384406 9916186 12768441 45662478 12152019 8245835 5689260 7972899 5786019 39846032 1980583554 33402483 0.94600 0.95360 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: AFFILIATE REVENUE - 2017 AMOUNT: $ 18,407. 2018 AMOUNT: $ 15,030. 2019 AMOUNT: $ 14,103. 2020 AMOUNT: $ 16,363. 2021 AMOUNT: $ 28,524. FUNDRAISING AND GAMING EVENTS - 2017 AMOUNT: $ 10,443,879. 2018 AMOUNT: $ 7,532,657. 2019 AMOUNT: $ 4,700,628. 2020 AMOUNT: $ 6,637,711. 2021 AMOUNT: $ 3,959,917. INCOME FROM SALES OF INVENTORY - 2017 AMOUNT: $ 318,798. 2018 AMOUNT: $ 242,384. 2019 AMOUNT: $ 132,390. 2020 AMOUNT: $ 115,729. 2021 AMOUNT: $ 99,420. GROUP CHAPTER REVENUE - 2017 AMOUNT: $ 520,936. 2018 AMOUNT: $ 247,444. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. LEGAL SETTLEMENT - 2017 AMOUNT: $ 734,166. 2018 AMOUNT: $ 0. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. CHAPTER RENT ABATEMENT - 2017 AMOUNT: $ 0. 2018 AMOUNT: $ 171,073. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. OTHER INCOME - 2017 AMOUNT: $ 115,833. 2018 AMOUNT: $ 37,247. 2019 AMOUNT: $ 842,139. 2020 AMOUNT: $ 1,203,096. 2021 AMOUNT: $ 334,434. SPONSORED PROCEEDS - 2017 AMOUNT: $ 0. 2018 AMOUNT: $ 0. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 1,363,724. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 1 284631 0 1 1 10008054 1 2189985 1 1234960 0 13717630 0 LINE 1A: VOLUNTEERS MOST OF THE ASSOCIATION'S ADVOCACY IS THROUGH VOLUNTEERS. ADDITIONALLY, THE ASSOCIATION HAS TRAINING TO DEVELOP AND ORGANIZE CHAPTER BASED GRASSROOTS ACTIVITIES. AS ALZHEIMER'S DISEASE AND RELATED DEMENTIAS THREATEN TO BANKRUPT FAMILIES, BUSINESSES AND THE HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR HIGH QUALITY HEALTHCARE AND LONG-TERM SERVICES AND SUPPORT FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES. THIS INCLUDES ADVOCACY FOR BETTER CARE FOR PEOPLE AND FAMILIES ALREADY FACING ALZHEIMER'S. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. LINE 1B: PAID STAFF OR MANAGEMENT THE ASSOCIATION HAS PAID STAFF WHO ENGAGE ON BEHALF OF THE ASSOCIATION IN PUBLIC POLICY WORK, INCLUDING EDUCATING POLICYMAKERS AND SUPPORTING THE ADVOCACY WORK OF VOLUNTEERS. LINE 1C: MEDIA ADVERTISEMENTS MEDIA ADVERTISEMENTS RAN IN WASHINGTON D.C. FOR KEY ADVOCACY AWARENESS OPPORTUNITIES DURING THE YEAR. LINE 1D: MAILING TO MEMBERS, LEGISLATORS OR THE PUBLIC IN KEEPING WITH PREVIOUS YEARS DURING THE PANDEMIC, NO MAILINGS WERE SENT OUT TO LEGISLATORS IN FY22. LINE 1E: PUBLICATIONS, OR PUBLISHED OR BROADCAST STATEMENTS THE ASSOCIATION DISTRIBUTED FEDERAL AND STATE UPDATES VIA EMAIL APPROXIMATELY 400 TIMES DURING THE YEAR. LINE 1F: GRANTS TO OTHER ORGANIZATIONS FOR LOBBYING PURPOSES THE ASSOCIATION MAKES A GRANT TO ALZHEIMER'S IMPACT MOVEMENT (AIM) WHICH IS USED FOR THE LOBBYING PURPOSES DISCUSSED ABOVE AND WHICH IS ALSO SHOWN ON THE FORM 990 OF AIM AS A LOBBYING EXPENSE. AS SUCH, THE AMOUNT OF THE GRANT IS REPORTED TWICE FOR TRANSPARENCY PURPOSES. LINE 1G: DIRECT CONTACT THE ASSOCIATION USES INTERNAL STAFF AND RETAINED LOBBYISTS TO EDUCATE POLICYMAKERS ABOUT THE ASSOCIATION'S POLICY RECOMMENDATIONS. LINE 1H: RALLIES, DEMONSTRATIONS, SEMINARS, ETC. THE AIM ADVOCACY FORUM WAS HELD IN PERSON IN MAY 2022. 24505547 2500 -2111453 6359802 16036792 24252597 252950 4771161 4771161 24505547 24252597 1490922 1490922 24252597 24043831 208766 1557825 1557825 24252597 24038631 5200 894633 894633 24043831 1.00000 0 0 592617 592617 1696978 289629 1407349 11783422 7229159 4554263 4579116 3474688 1104428 30864008 15474867 15389141 23047798 BENEFICIAL INTEREST 34943160 F COMMINGLED TRUST FUND 5702631 F LIMITED PARTNERHSIP 5226479 F ASSETS HELD IN TRUST 290027 F 46162297 DEFERRED RENT 8354573 GIFT ANNUITY OBLIGATIONS 5473244 13827817 X 412442490 -89598366 8190811 -4422924 -85830479 498272969 269717 3495892 3765609 502038578 447671301 8190816 71595 8262411 439408890 269717 3495892 3765609 443174499 PART V, LINE 4: INTENDED USES OF ENDOWMENT FUNDS A PORTION OF THE NET ASSETS WITH DONOR RESTRICTIONS ARE RESTRICTED AS INVESTMENTS IN PERPETUITY. THE ASSOCIATION'S ENDOWMENT ONLY CONSISTS OF DONOR-RESTRICTED ENDOWMENT FUNDS. NET ASSETS ASSOCIATED WITH THE ASSOCIATION'S ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OF DONOR-IMPOSED RESTRICTIONS. DONORS RESTRICT THE EARNINGS OF SOME OF THE ASSOCIATION'S ENDOWMENT FUNDS TO FUND THE ASSOCIATION'S RESEARCH PROGRAM. IN ACCORDANCE WITH DONOR STIPULATIONS, THE INCOME GENERATED FROM THESE ASSETS IS RESTRICTED FOR RESEARCH (APPROXIMATELY 56%) OR NOT PURPOSE RESTRICTED (APPROXIMATELY 44%). THE ASSOCIATION ACCOUNTS FOR ENDOWMENT NET ASSETS BY PRESERVING THE FAIR VALUE OF THE ORIGINAL GIFT AS OF THE GIFT DATE OF THE DONOR-RESTRICTED ENDOWMENT FUND ABSENT EXPLICIT DONOR STIPULATIONS TO THE CONTRARY. AS A RESULT, THE ASSOCIATION CLASSIFIES AS PERMANENTLY RESTRICTED NET ASSETS (1) THE ORIGINAL VALUE OF GIFTS DONATED TO THE PERMANENT ENDOWMENT, (2) THE ORIGINAL VALUE OF SUBSEQUENT GIFTS TO THE PERMANENT ENDOWMENT AND (3) ACCUMULATIONS TO THE PERMANENT ENDOWMENT MADE IN ACCORDANCE WITH THE DIRECTION OF THE APPLICABLE DONOR GIFT INSTRUMENT AT THE TIME THE ACCUMULATION IS ADDED TO THE ENDOWMENT FUND. THE ASSOCIATION CONSIDERS THE FOLLOWING FACTORS IN MAKING A DETERMINATION TO APPROPRIATE OR ACCUMULATE DONOR-RESTRICTED ENDOWMENT FUNDS: - THE DURATION AND PRESERVATION OF THE FUND; - THE PURPOSES OF THE ASSOCIATION AND THE DONOR-RESTRICTED ENDOWMENT FUND; - GENERAL ECONOMIC CONDITIONS; - THE POSSIBLE EFFECTS OF INFLATION AND DEFLATION; - THE EXPECTED TOTAL RETURN FROM INCOME AND THE APPRECIATION OF INVESTMENTS; - OTHER RESOURCES OF THE ASSOCIATION; AND - THE INVESTMENT POLICIES OF THE ASSOCIATION. THE ASSOCIATION HAS ADOPTED AN INVESTMENT POLICY THAT ATTEMPTS TO PROVIDE A PREDICTABLE STREAM OF FUNDING TO PROGRAMS SUPPORTED BY ITS ENDOWMENT WHILE SEEKING TO MAINTAIN THE PURCHASING POWER OF THE ENDOWMENT ASSETS. AS OF JUNE 30, 2022 AND 2021, ENDOWMENT ASSETS ONLY INCLUDE THOSE ASSETS OF DONOR-RESTRICTED FUNDS THAT THE ASSOCIATION MUST HOLD IN PERPETUITY, AS THE ASSOCIATION DOES NOT HAVE ANY BOARD-DESIGNATED ENDOWMENT FUNDS. UNDER THIS POLICY, AS APPROVED BY THE BOARD OF DIRECTORS, THE ENDOWMENT ASSETS ARE INVESTED IN A MANNER THAT IS INTENDED TO PROVIDE ADEQUATE LIQUIDITY, MAXIMIZING RETURNS ON ALL FUNDS INVESTED AND ACHIEVING FULL EMPLOYMENT OF ALL AVAILABLE FUNDS AS EARNING ASSETS. THE ASSOCIATION HAS AN ACTIVE FINANCE COMMITTEE AND INVESTMENT SUB-COMMITTEE THAT MEETS REGULARLY TO ENSURE THAT THE OBJECTIVES OF THE INVESTMENT POLICY ARE MET, AND THAT THE STRATEGIES USED TO MEET THE OBJECTIVES ARE IN ACCORDANCE WITH THE INVESTMENT POLICY. THE ASSOCIATION'S POLICY IS TO APPROPRIATE SPENDING AMOUNTS DEEMED PRUDENT FOR DONOR-RESTRICTED FUNDS. ENDOWMENT NET ASSETS CONSIST OF DONOR-RELATED ENDOWMENT FUNDS. DURING THE YEAR ENDED JUNE 30, 2022, THE ALZHEIMER'S ASSOCIATION RECLASSIFIED PERPETUAL TRUSTS THAT WERE IMPROPERLY PRESENTED AS ENDOWMENTS IN THE FOOTNOTES TO THE AUDITED FINANCIAL STATEMENTS. THE ALZHEIMER'S ASSOCIATION AMENDED THE ENDOWMENT REPORTING IN THE CURRENT YEAR OF SCHEDULE D PART V TO REFLECT THE CORRECT BALANCE. PART X, LINE 2: FIN 48 THE ASSOCIATION AND ALZHEIMER'S IMPACT MOVEMENT (AIM) HAVE RECEIVED FAVORABLE DETERMINATION LETTERS FROM THE INTERNAL REVENUE SERVICE, STATING THAT THEY ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER THE PROVISIONS OF SECTION 501(A) OF THE INTERNAL REVENUE CODE OF 1986 (IRC), AS ORGANIZATIONS DESCRIBED IN SECTIONS 501(C)(3) AND 501(C)(4), RESPECTIVELY, EXCEPT FOR INCOME TAXES PERTAINING TO UNRELATED BUSINESS INCOME. ALZHEIMER'S IMPACT MOVEMENT POLITICAL ACTION COMMITTEE (AIMPAC) IS A POLITICAL ACTION COMMITTEE ORGANIZATION EXEMPT FROM FEDERAL TAXES UNDER SECTION 527 OF THE IRC. THE ALZHEIMER'S ASSOCIATION INTERNATIONAL IS A NOT-FOR-PROFIT CANADIAN ENTITY. THE COALITION OF NEW YORK STATE ALZHEIMER'S ASSOCIATION CHAPTERS, INC. IS A NOT-FOR-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE IRC AND HAS NOT BEEN CLASSIFIED AS A PRIVATE FOUNDATION; THEREFORE, NO PROVISION FOR INCOME TAX HAS BEEN MADE IN THE FINANCIAL STATEMENTS. THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ISSUED GUIDANCE THAT REQUIRES TAX EFFECTS FROM UNCERTAIN TAX POSITIONS TO BE RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS ONLY IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. MANAGEMENT HAS DETERMINED THERE ARE NO MATERIAL UNCERTAIN POSITIONS THAT REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS AND, AS SUCH, NO PROVISION FOR INCOME TAXES IS REFLECTED. ADDITIONALLY, THERE ARE NO INTEREST OR PENALTIES RECOGNIZED IN THE CONSOLIDATED STATEMENT OF ACTIVITIES OR STATEMENT OF FINANCIAL POSITION. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF PERPETUAL TRUSTS -3,640,879. CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS -801,308. GAMING EXPENSES 19,263. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 3,551,567. COST OF GOODS SOLD -55,675. PART XII, LINE 2D - OTHER ADJUSTMENTS: BAD DEBT EXPENSE 1,581,293. RESCINDED GRANTS -1,528,961. GAMING EXPENSES 19,263. PART XII, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 3,551,567. COST OF GOODS SOLD -55,675. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 9468520 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 2238135 NORTH AMERICA 0 0 GRANTMAKING 1475350 SOUTH AMERICA 0 0 GRANTMAKING 1210182 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 999094 SUB-SAHARAN AFRICA 0 0 GRANTMAKING 329700 SOUTH ASIA 0 0 GRANTMAKING 25000 0 0 0 0 0 0 15745981 0 15745981 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PROGRAM SUPPORT 324782 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PROGRAM SUPPORT 149767 WIRE 0 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, PROGRAM SUPPORT 149097 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PROGRAM SUPPORT 174999 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PROGRAM SUPPORT 450000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PROGRAM SUPPORT 149100 WIRE 0 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES PROGRAM SUPPORT 150000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PROGRAM SUPPORT 175000 WIRE 0 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES PROGRAM SUPPORT 262500 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 800000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 304970 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 274929 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 119569 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 99961 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 169302 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 149985 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 148600 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 24995 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 799882 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 623944 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 765942 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 298992 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 60000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 149931 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 24948 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 155000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 149997 WIRE 0 SUB-SAHARAN AFRICA PROGRAM SUPPORT 154700 WIRE 0 SUB-SAHARAN AFRICA PROGRAM SUPPORT 150000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 174990 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 149600 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 136358 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 100000 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 147635 WIRE 0 SOUTH ASIA PROGRAM SUPPORT 25000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 169522 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 25000 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 25000 WIRE 0 MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 24998 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 578500 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 24904 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 300000 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 175000 WIRE 0 MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 799999 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 175000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 162615 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 175000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 259996 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 150000 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 162765 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 81810 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 149969 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 139877 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 50000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 126442 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 24998 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 NORTH AMERICA PROGRAM SUPPORT 226917 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 175000 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 24992 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 119732 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 625000 WIRE 0 SOUTH AMERICA PROGRAM SUPPORT 132000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 125500 WIRE 0 SUB-SAHARAN AFRICA PROGRAM SUPPORT 25000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 790000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 150000 WIRE 0 EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 145970 WIRE 0 83 1 0 0 1 0 0 0 PART I, LINE 2: PROCEDURE FOR MONITORING USE OF GRANT FUNDS OUTSIDE U.S. THE OVER-SIGHT OF THE SCIENTIFIC INTEGRITY OF THE ALZHEIMER'S ASSOCIATION NATIONAL AND INTERNATIONAL RESEARCH GRANT PROGRAM IS THREE-FOLD. FIRST, THE ALZHEIMER'S ASSOCIATION VOLUNTARY MEDICAL & SCIENTIFIC ADVISORY GROUP (MSAG), THE ALZHEIMER'S ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM (IRGP) COUNCIL, AND ALZHEIMER'S ASSOCIATION MEDICAL & SCIENTIFIC RELATIONS DIVISION, ENSURES PEER REVIEW AND HIGH QUALITY OF FUNDED AWARDS DURING THE GRANT REVIEW PROCESS AND DEVELOPS FOCUSED REQUESTS FOR APPLICATIONS (RFAS) BASED ON IDENTIFIED NEEDS IN THE ALZHEIMER'S AND ALL DEMENTIA RESEARCH COMMUNITY. SECOND, THE ALZHEIMER'S ASSOCIATION IS ENGAGED IN A PORTFOLIO ANALYSIS OF SCIENTIFIC AREAS OF INVESTMENT TO MONITOR THE DIVERSITY OF THE GRANTS PORTFOLIO, POTENTIAL GAPS IN RESEARCH FUNDING, AND POTENTIAL OVERLAP OF AREAS FUNDED. THE ANALYSIS INFORMS FUTURE FUNDING DECISIONS, STRATEGIC ACTIVITIES AND AREAS OF FUTURE-RFA FOCUS. THIRD, THERE IS A DETAILED PROCESS ONCE A GRANT IS AWARDED TO MONITOR PROGRAM AND SCIENTIFIC AND FINANCIAL INTEGRITY AND, FOR THE FELLOWSHIP PROGRAM, THERE IS A MENTOR EVALUATION. THE ALZHEIMER'S ASSOCIATION MONITORS THE USE OF GRANT FUNDS BOTH INSIDE AND OUTSIDE OF THE UNITED STATES AS FOLLOWS: ALL AWARDEES ARE REQUIRED TO PROVIDE ANNUAL AND IN SOME CASES BI-ANNUAL REPORTING TO THE ALZHEIMER'S ASSOCIATION ON BOTH THE STATUS OF THE RESEARCH PROJECT AND FINANCIAL EXPENDITURES ASSOCIATED WITH THE PROJECT. SEVERAL PROGRAMS ARE LEVERAGED FUNDING OPPORTUNITIES WITH PARTNER ORGANIZATIONS. THESE RESEARCH PROJECTS AND FINANCIAL EXPENDITURE REPORTS ARE SHARED BETWEEN THE PARTNER ORGANIZATION(S). SIXTY DAYS PRIOR TO THE ANNIVERSARY OF THE AWARD START DATE, AN ALZHEIMER'S ASSOCIATION GRANT SPECIALIST NOTIFIES ALL RESEARCHERS AND ALL DESIGNATED INSTITUTIONAL FINANCIAL OFFICIALS WITH FISCAL RESPONSIBILITY FOR THE AWARD OF THE REQUIRED REPORTS, WHICH INCLUDE AN INTERIM SCIENTIFIC REPORT, INTERIM FINANCIAL REPORT, MENTOR EVALUATION, DOCUMENTATION OF ANY PUBLICATIONS AS A RESULT OF ASSOCIATION FUNDING, AND ANNUAL VERIFICATION OF REQUIRED ETHICAL (ANIMAL AND HUMAN AND RECOMBINANT DNA APPROVALS) APPROVALS. THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD CANNOT BE THE PRIMARY INVESTIGATOR OF THE PROJECT. THE ALZHEIMER'S ASSOCIATION PROVIDES A TEMPLATE FOR THE INTERIM SCIENTIFIC REPORT AND A TEMPLATE FOR THE INTERIM FINANCIAL REPORT AND THE MENTOR EVALUATION, BOTH OF WHICH ARE AVAILABLE FOR DOWNLOAD BY THE RESEARCHERS AS WELL AS THE OFFICIAL WITH FISCAL RESPONSIBILITY FOR THE GRANT AT THE AWARDED INSTITUTION AT HTTPS://PROPOSALCENTRAL.COM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WITH FISCAL RESPONSIBILITY, AND FOR THE FELLOWSHIP PROGRAMS, THE MENTOR EVALUATION MUST BE SIGNED BY MENTOR AND FELLOW AND ALL REPORTS MUST BE UPLOADED BY THE AWARD RECIPIENT TO PROPOSALCENTRAL. AFTER RECEIPT, ALL FINANCIAL REPORTS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION SPECIALIST FOR ACCURACY AND CONSISTENCY WITH THE AGREED UPON BUDGET. IN ADDITION, THE ASSOCIATION REQUIRES PROTOCOL CONTINUATION APPROVAL (I.E., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL ETHICAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCOL (RDNA)) ANNUALLY, IF APPLICABLE FOR THE RESEARCH PROJECT. ANY SUBSEQUENT PAYMENTS TO GRANT AWARDEES ARE GENERATED AFTER THE RECEIPT OF THESE DOCUMENTS AND APPROVAL BY THE CHIEF SCIENCE OFFICER, MEDICAL AND SCIENTIFIC RELATIONS. AT THE CONCLUSION OF THE AWARD, ALL REPORTS/PUBLICATION(S) ARE DUE 90 DAYS AFTER THE AWARD EXPIRES AND MUST BE UPLOADED TO THE PROPOSALCENTRAL ONLINE SYSTEM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD. PUBLICATION(S) AS ACCEPTED ARE UPLOADED TO PROPOSALCENTRAL DURING AND AFTER THE DURATION OF THE GRANT. IT IS EXPECTED THAT AWARDEES WILL CONTINUE TO MAINTAIN RECORD OF ANY PUBLICATION(S) ACKNOWLEDGING THE ALZHEIMER'S ASSOCIATION. DATA GENERATED AS A RESULT OF ALZHEIMER'S ASSOCIATION FUNDED WORK IS SUBJECT TO DATA SHARING, AS A CONDITION OF AWARD. DATA AND OTHER OUTPUTS OF THE PROJECT ARE SUBJECTED TO THIS POLICY FOR QUICK, REASONABLE SUBMISSIONS FOR COMPLETED WORK. FURTHER, AWARDEES HAVE THE OPPORTUNITY TO SUBMIT/SHARE DATA, AS APPLICABLE, THROUGH THE GLOBAL ALZHEIMER'S ASSOCIATION INTERACTIVE NETWORK (GAAIN*), A GLOBAL INFRASTRUCTURE CONNECTING RESEARCH STUDIES FROM AROUND THE WORLD THROUGH ONE PORTAL WHERE DATA CAN BE INTERROGATED IN AGGREGATE FOR ANALYSIS USING A VIRTUAL MACHINE. GAAIN IS WHOLLY FUNDED BY THE ALZHEIMER'S ASSOCIATION. IN ADDITION, THE ASSOCIATION REQUESTS, MONITORS, AND FOLLOWS-UP TO ENSURE SUBMISSION COMPLIANCE ON ALL AWARDED GRANTS AND THAT FINANCIAL REPORTING REQUIREMENTS ARE MET. AWARDEES' FINANCIAL REPORTS ARE REVIEWED ANNUALLY TO ENSURE ELIGIBILITY FOR CONTINUED FUNDING. DELINQUENT REPORT(S) MAY RESULT IN THE WITHDRAWAL OF FUNDING. RESEARCHERS ARE INFORMED THAT DELINQUENT REPORTING COULD LEAD TO WITHDRAWAL OF FUNDING WHEN THE REQUEST FOR ANNUAL REPORT(S) IS SENT. IF FUNDING IS WITHDRAWN DUE TO DELINQUENT REPORTS, ANY UNSPENT FUNDS MUST BE RETURNED TO THE ALZHEIMER'S ASSOCIATION. FOREIGN INSTITUTIONS ARE REQUIRED TO SUBMIT ONE OF THE FOLLOWING AS VERIFICATION OF NON-PROFIT STATUS: - ORGANIZATION'S CHARTER, BYLAWS AND OTHER GOVERNING DOCUMENTS (IN ENGLISH, IF POSSIBLE). IN CASES WHERE TRANSLATION IS NOT POSSIBLE, A DATED AND SIGNED LETTER IN ENGLISH FROM THE RECTOR OR OTHER AUTHORIZED SIGNING OFFICIAL OF THE INSTITUTION IS ACCEPTABLE. - DOCUMENTATION OF NON-PROFIT DESIGNATION FROM ORGANIZATION'S GOVERNMENT. FOR-PROFIT ORGANIZATIONS ARE NOT ELIGIBLE TO APPLY TO THE ALZHEIMER'S ASSOCIATION'S INTERNATIONAL RESEARCH GRANT PROGRAM, WITH THE EXCEPTION OF THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT PROGRAM, ALZHEIMER'S INNOVATION AWARD AND CERTAIN PARTNERSHIP PROGRAMS, INCLUDING TAU PIPELINE ENABLING PROGRAM (T-PEP). ELIGIBILITY OF ORGANIZATIONS APPLICABLE FOR A PROGRAM ARE DETAILED IN THAT PROGRAM'S RFA. UNLESS OTHERWISE STATED IN PROGRAM, ALL INSTITUTIONS ARE REQUIRED TO SUBMIT VERIFICATION OF THEIR NON-PROFIT STATUS DATED WITHIN THE LAST FIVE YEARS (E.G., IRS TAX DETERMINATION LETTER). IF THE IRS DETERMINATION LETTER IS DATED PRIOR TO THIS FIVE-YEAR PERIOD, THE INSTITUTION IS REQUIRED TO PROVIDE DOCUMENTATION FROM AN AUTHORIZED SIGNING OFFICIAL IN THEIR GRANTS AND CONTRACTS OFFICE OR OFFICE OF SPONSORED RESEARCH TO CONFIRM THERE HAS NOT BEEN A STATUS CHANGE FOR THE ORGANIZATION. FOR THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT PROGRAM AND OTHER PROGRAMS WITH FOR-PROFIT AWARDEES, ANY FOR-PROFIT APPLICANT IS REQUIRED TO SUBMIT THE ORGANIZATION'S FINANCIAL STATEMENTS. AS PART OF THE APPLICATION PROCESS, APPLICANTS ARE TO UPLOAD A W-8BEN-E FORM THAT HAS BEEN DATED AND SIGNED BY AN AUTHORIZED SIGNING OFFICIAL. THIS FORM VERIFIES THAT AN INSTITUTION OR ORGANIZATION IS DESIGNATED AS A 501(C)(3) OR OTHER NON-PROFIT ENTITY. FOR PROFIT ORGANIZATIONS MUST SUBMIT DOCUMENTATION OF NET ASSETS AND ANNUAL EARNINGS, IN ADDITION TO THE W-8BEN-E FORM FOR CONSIDERATION. THESE FORMS ARE UPLOADED WITHIN THEIR SUBMITTED APPLICATION TO PROPOSALCENTRAL. AFTER RECEIPT, THESE FORMS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANT SPECIALIST. FOLLOWING REVIEW BY A GRANT SPECIALIST, APPLICATIONS ARE THEN MOVED FORWARD TO PEER-REVIEW. IF AWARDED, THE ALZHEIMER'S ASSOCIATION GRANT SPECIALIST INCLUDES THE APPROPRIATE FORMS IN PAYMENT REQUESTS FOR GRANT FUNDING PAYMENTS. PRIOR TO AWARD CONFIRMATION, THE MEDICAL AND SCIENTIFIC RELATIONS DIVISION VERIFIES THAT EACH INSTITUTION IS COMPLIANT WITH THE U.S. PATRIOT ACT AND DOES NOT APPEAR ON THE SPECIALLY DESIGNATED NATIONALS (SDN) LISTS. PRIOR TO PAYMENT, EACH FUNDED ALZHEIMER'S ASSOCIATION GRANT AWARDEE (I.E. THE INSTITUTION) IS VERIFIED FOR COMPLIANCE WITH THE U.S. PATRIOT ACT (THROUGH OFAC). THE GRANT SPECIALIST CONFIRMS ELIGIBILITY AND PROVIDES THIS DOCUMENTATION TO THE GRANT ONLINE FILE AT PROPOSALCENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WILL BE IMMEDIATELY REPORTED TO THE ALZHEIMER'S ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. FOR TRANSACTIONS UNRELATED TO THE INTERNATIONAL RESEARCH GRANT PROGRAM IN THE MEDICAL AND SCIENTIFIC DEPARTMENT, THE SAME FINANCIAL DOCUMENTATION IS REVIEWED. THE ALZHEIMER'S ASSOCIATION MONITORS THE SCIENTIFIC ADVANCES OF THE ASSOCIATION'S GRANT AWARDEES BY MAINTAINING RECORDS OF PUBLICATIONS, PRESENTATIONS, AND INTELLECTUAL PROPERTY THAT RESULT FROM FUNDED STUDIES. THE ASSOCIATION REQUIRES THE GRANT RECIPIENT TO NOTIFY THE ALZHEIMER'S ASSOCIATION ON AN ANNUAL BASIS WITH UPDATES TO THESE RECORDS. FOLLOW-ON FUNDING FROM FEDERAL AGENCIES IS ALSO MONITORED. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. PART I, LINE 3: METHOD USED TO ACCOUNT FOR EXPENDITURES AND GRANTS THE ALZHEIMER'S ASSOCIATION ACCOUNTS FOR EXPENDITURES, CASH GRANTS, AND NONCASH ASSISTANCE USING THE ACCRUAL METHOD. PART II, LINE 1: METHOD USED TO ACCOUNT FOR EXPENDITURES AND GRANTS THE ALZHEIMER'S ASSOCIATION ACCOUNTS FOR EXPENDITURES, CASH GRANTS, AND NONCASH ASSISTANCE USING THE ACCRUAL METHOD. PART III ACCOUNTING METHOD: X X X X X X X 1 THD 80 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 MAIL 0 44700254 1811118 42889136 CDR 16900 SCIENCE DRIVE SUITE 210 BOWIE MD 20715 EMAIL 0 34930304 282400 34647904 79630558 2093518 77537040 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC PTC-GALA 3809200 3191641 617559 390912 88380 146425 52315 NAPA VALLEY 1943277 1563002 380275 181113 85783 6223 177151 65 20810086 17872678 2937408 432711 689703 1782433 284536 4718452 26562563 22627321 3935242 432711 1261728 1956596 437184 4947918 9036137 -5100895 24675 19263 0 24675 19263 19263 5412 IA MI OH OR 1 0 1 0 1.00000 LYNNE CAREY 225 N MICHIGAN AVE CHICAGO IL 60601 0 LYNNE CAREY ALZHEIMER'S ASSOCIATION HAS MORE GAMING MANAGERS THAN LYNNE CAREY LISTED ON PART III, LINE 16. THIS INFORMATION IS AVAILABLE UPON REQUEST FROM ALZHEIMER'S HOME OFFICE. X 0 PART I, LINE 2B, BOX (III): FUNDRAISING CONSULTANT - CONTROL ARRANGEMENT THE ALZHEIMER'S ASSOCIATION ENGAGES THOMPSON, HABIB & DENISON INC. (THD) FOR PROFESSIONAL FUNDRAISING CONSULTANT SERVICES. A DESCRIPTION OF THE ARRANGEMENT IS LISTED BELOW: DIRECT MARKETING STRATEGY AND PROGRAM DIRECTION; PRODUCTION MANAGEMENT; DATABASE MANAGEMENT; BUDGETING MANAGEMENT; AND REPORT MANAGEMENT. THE ALZHEIMER'S ASSOCIATION ENGAGES CREATIVE DIRECT RESPONSE, INC. (CDR) FOR PROFESSIONAL FUNDRAISING DIGITAL MARKETING CONSULTANT SERVICES. A DESCRIPTION OF THE ARRANGEMENT IS LISTED BELOW: DIGITAL MARKETING STRATEGY AND PROGRAM DIRECTION; E-MAIL PROGRAM MANAGEMENT; PRODUCTION MANAGEMENT; DATABASE MANAGEMENT; AND BUDGETING MANAGEMENT. PART I, LINE 2B, BOX (VI): FUNDRAISING CONSULTANT - FEE ARRANGEMENT THE AGREEMENT BETWEEN THOMPSON, HABIB & DENISON (THD) AND THE ALZHEIMER'S ASSOCIATION IS NOT A PERCENTAGE-BASED AGREEMENT. THD IS PAID A FIXED FEE PER MONTH. THE ALZHEIMER'S ASSOCIATION EXERCISES CONTROL AND APPROVAL OVER THE CONTENT AND FREQUENCY OF ALL SOLICITATIONS. THE AGREEMENT BETWEEN CREATIVE DIRECT RESPONSE, INC. (CDR) AND THE ALZHEIMER'S ASSOCIATION IS NOT A PERCENTAGE-BASED AGREEMENT. CDR IS PAID A FIXED FEE PER MONTH. THE ALZHEIMER'S ASSOCIATION EXERCISES CONTROL AND APPROVAL. 1 ALBANY MEDICAL COLLEGE 47 NEW SCOTLAND AVENUE RESEARCH ADMINISTRATION ALBANY NY 12208 141338310 501(C)(3) 150000 0 PROGRAM SUPPORT ALZHEIMERS IMPACT MOVEMENT 225 NORTH MICHIGAN AVE CHICAGO IL 60601 271961435 501(C)(4) 10008054 0 PUBLIC POLICY AMERICAN BRAIN FOUNDATION 201 CHICAGO AVE MINNEAPOLIS MN 55415 411717098 501(C)(3) 1531667 0 PROGRAM SUPPORT AMERICAN COLLEGE OF RADIOLOGY 1891 PRESTON WHITE DRIVE RESTON VA 20191 362261602 501(C)(3) 1547493 0 PROGRAM SUPPORT ARIZONA STATE UNIVERSITY PO BOX 876011 TEMPE AZ 85287 860196696 501(C)(3) 300000 0 PROGRAM SUPPORT ARTERY THERAPEUTICS INC 10 DUBERSTEIN DRIVE SAN RAMON CA 94583 830389565 800000 0 PROGRAM SUPPORT BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA MS BCM 310 HOUSTON TX 77030 741613878 501(C)(3) 174500 0 PROGRAM SUPPORT BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVENUE BOSTON MA 02215 042103881 501(C)(3) 300000 0 PROGRAM SUPPORT BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501(C)(3) 175000 0 PROGRAM SUPPORT BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MA 02115 042312909 501(C)(3) 664884 0 PROGRAM SUPPORT BROAD INSTITUTE INC 415 MAIN STREET CAMBRIDGE MA 02142 263428781 501(C)(3) 299818 0 PROGRAM SUPPORT BROWN UNIVERSITY 350 EDDY STREET BOX 1929 PROVIDENCE RI 02912 050258809 501(C)(3) 300000 0 PROGRAM SUPPORT CALIFORNIA STATE UNIVERSITY 4910 N CHESTNUT AVE FRESNO CA 93726 946003272 501(C)(3) 25000 0 PROGRAM SUPPORT CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVENUE CLEVELAND OH 44106 341018992 501(C)(3) 324916 0 PROGRAM SUPPORT CITY OF LAUDERDALE LAKES 4320 NW 36TH ST FORT LAUDERDALE FL 33319 590974050 501(C)(3) 8659 0 PROGRAM SUPPORT CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 043167352 501(C)(3) 162297 0 PROGRAM SUPPORT COLORADO STATE UNIVERSITY 2002 CAMPUS DELIVERY FORT COLLINS CO 80523 846000545 501(C)(3) 149947 0 PROGRAM SUPPORT COLUMBIA UNIVERSITY MEDICAL CENTER 630 WEST 168TH STREET NEW YORK NY 10032 135598093 501(C)(3) 1339961 0 PROGRAM SUPPORT CORNELL UNIVERSITY 373 PINE TREE ROAD ITHACA NY 14850 150532082 501(C)(3) 450000 0 PROGRAM SUPPORT DUKE UNIVERSITY 2200 W MAIN STREET SUITE 710 DURHAM NC 27705 560532129 501(C)(3) 729790 0 PROGRAM SUPPORT EMORY UNIVERSITY 1599 CLIFTON ROAD NE ATLANTA GA 30322 580566256 501(C)(3) 642772 0 PROGRAM SUPPORT FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH 11400 ROCKVILLE PIKE SUITE 600 NORTH BETHESDA MD 20852 521986675 501(C)(3) 834717 0 PROGRAM SUPPORT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE BOX 1075 NEW YORK NY 10029 136171197 501(C)(3) 1324990 0 PROGRAM SUPPORT INDIANA UNIVERSITY 509 E 3RD STREET BLOOMINGTON IN 47401 356001673 501(C)(3) 886466 0 PROGRAM SUPPORT IOWA STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY 505 MORRILL ROAD AMES IA 50011 426004224 501(C)(3) 148388 0 PROGRAM SUPPORT JOHNS HOPKINS UNIVERSITY - KRIEGER SCHOOL OF ARTS & SCIENCES 3400 N CHARLES STREET SUITE N600 BALTIMORE MD 21218 520595110 501(C)(3) 175000 0 PROGRAM SUPPORT KAISER FOUNDATION HEALTH PLAN OF COLORADO 2550 S PARKER RD SUITE 200 AURORA CO 80014 840591617 501(C)(3) 250000 0 PROGRAM SUPPORT KENNESAW STATE UNIVERSITY RESEARCH AND SERVICE FOUNDATION 1000 CHASTAIN ROAD MD 0111 KENNESAW GA 30144 371535589 501(C)(3) 149974 0 PROGRAM SUPPORT LEHIGH UNIVERSITY 526 BRODHEAD AVENUE BETHLEHEM PA 18015 240795445 501(C)(3) 149951 0 PROGRAM SUPPORT LOWCOUNTRY CENTER FOR VETERANS RESEARCH 22 WESTEDGE STREET SUITE 410 CHARLESTON SC 29403 562054871 501(C)(3) 50000 0 PROGRAM SUPPORT LOYOLA UNIVERSITY-CHICAGO 2160 SOUTH FIRST AVENUE MAYWOOD IL 60153 361408475 501(C)(3) 150000 0 PROGRAM SUPPORT MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 042697983 501(C)(3) 1187533 0 PROGRAM SUPPORT MAYO CLINIC ARIZONA 13400 EAST SHEA BOULEVARD SCJ 1ST FLOOR SCOTTSDALE AZ 85259 860800150 501(C)(3) 140000 0 PROGRAM SUPPORT MAYO CLINIC JACKSONVILLE 4500 SAN PABLO ROAD JACKSONVILLE FL 32224 593337028 501(C)(3) 904951 0 PROGRAM SUPPORT MEDICAL UNIVERSITY OF SOUTH CAROLINA 179 ASHLEY AVE CHARLESTON SC 29425 576000722 501(C)(3) 150000 0 PROGRAM SUPPORT MICHIGAN STATE UNIVERSITY 426 AUDITORIUM ROAD EAST LANSING MI 48824 386005984 501(C)(3) 349033 0 PROGRAM SUPPORT NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE 9000 ROCKVILLE PIKE BETHESDA MD 20892 520858115 501(C)(3) 175000 0 PROGRAM SUPPORT NEVADA SYSTEM OF HIGHER EDUCATION 4505 MARYLAND PARKWAY BOX 451055 LAS VEGAS NV 89154 886000024 501(C)(3) 298989 0 PROGRAM SUPPORT NEW YORK INSTITUTE OF TECHNOLOGY NORTHERN BOULEVARD GERRY HOUSE OLD WESTBURY NY 11568 111788788 501(C)(3) 150000 0 PROGRAM SUPPORT NEW YORK UNIVERSITY 665 BROADWAY SUITE 801 NEW YORK NY 10016 135562308 501(C)(3) 665000 0 PROGRAM SUPPORT NORTHWESTERN UNIVERSITY 750 NORTH LAKE SHORE DRIVE 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 293530 0 PROGRAM SUPPORT OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK RD PORTLAND OR 97239 931176109 501(C)(3) 911965 0 PROGRAM SUPPORT PHARMATROPHIX INC 2198 STERLING AVE MENLO PARK CA 94025 141973571 890000 0 PROGRAM SUPPORT REGENERATIVE RESEARCH FOUNDATION ONE DISCOVERY DRIVE RENSSELAER NY 12144 203654626 501(C)(3) 140000 0 PROGRAM SUPPORT REGENTS OF THE UNIVERSITY OF MINNESOTA - TWIN CITIES 420 DELAWARE STREET SE MINNEAPOLIS MN 55455 416007513 501(C)(3) 145861 0 PROGRAM SUPPORT RESEARCH FOUNDATION FOR MENTAL HYGIENE INC 150 BROADWAY SUITE 301 MENANDS NY 12204 141410842 501(C)(3) 315000 0 PROGRAM SUPPORT RESEARCH FOUNDATION OF CUNY 85 ST NICHOLAS TERRACE NEW YORK NY 10031 131988190 501(C)(3) 150000 0 PROGRAM SUPPORT RUSH UNIVERSITY MEDICAL CENTER 1653 W CONGRESS PARKWAY CHICAGO IL 60612 362174823 501(C)(3) 447017 0 PROGRAM SUPPORT SOUTH CAROLINA DEPARTMENT OF AGING 1301 GERVAIS ST STE 200 COLUMBIA SC 29201 576000286 501(C)(3) 1351651 0 PROGRAM SUPPORT SOUTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION 5901 E SEVENTH ST LONG BEACH CA 90822 330331855 501(C)(3) 100000 0 PROGRAM SUPPORT ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MAIL STOP 733 MEMPHIS TN 38105 620646012 501(C)(3) 150000 0 PROGRAM SUPPORT THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 485 BROADWAY ST REDWOOD CITY CA 94063 941156365 501(C)(3) 325000 0 PROGRAM SUPPORT THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 350 COMMUNITY DRIVE MANHASSET NY 11030 112673595 501(C)(3) 150000 0 PROGRAM SUPPORT THE GEORGE WASHINGTON UNIVERSITY 1922 F STREET NW 4TH FLOOR WASHINGTON DC 20052 530196584 501(C)(3) 66000 0 PROGRAM SUPPORT THE J DAVID GLADSTONE INSTITUTES 1650 OWENS STREET SAN FRANCISCO CA 94158 237203666 501(C)(3) 179104 0 PROGRAM SUPPORT THE JACKSON LABORATORY 600 MAIN STREET BAR HARBOR ME 04906 010211513 501(C)(3) 789902 0 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA BERKELEY 1608 FOURTH STREET SUITE 220 BERKELEY CA 94710 946002123 501(C)(3) 140000 0 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE 160 ALDRICH HALL IRVINE CA 92697 952226406 501(C)(3) 175000 0 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BOULEVARD SUITE 700 LOS ANGELES CA 90095 956006143 501(C)(3) 299305 0 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE DEPT 0934 LA JOLLA CA 92093 956006144 501(C)(3) 644996 0 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 3333 CALIFORNIA STREET SUITE 315 SAN FRANCISCO CA 94143 946036493 501(C)(3) 2188525 0 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 48109 386006309 501(C)(3) 980834 0 PROGRAM SUPPORT THE RESEARCH FOUNDATION OF SUNY 35 STATE STREET ALBANY NY 12207 141368361 501(C)(3) 298990 0 PROGRAM SUPPORT THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 10010 NORTH TORREY PINES ROAD LA JOLLA CA 92037 952160097 501(C)(3) 175000 0 PROGRAM SUPPORT THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET FRANKLIN BUILDING 5TH FLOOR PHILADELPHIA PA 19104 231352685 501(C)(3) 879551 0 PROGRAM SUPPORT THE UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN 901 WEST ILLINOIS STREET URBANA IL 61801 376000511 501(C)(3) 7500 0 PROGRAM SUPPORT THE UNIVERSITY OF IOWA 2 GILMORE HALL IOWA CITY IA 52242 426004813 501(C)(3) 311363 0 PROGRAM SUPPORT THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 104 AIRPORT DRIVE SUITE 2200 CAMPUS BOX 1350 CHAPEL HILL NC 27599 566001393 501(C)(3) 844705 0 PROGRAM SUPPORT THE UNIVERSITY OF TEXAS AT AUSTIN 3925 WEST BRAKER LN SUITE 3340 AUSTIN TX 78759 746000203 501(C)(3) 594875 0 PROGRAM SUPPORT THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 7000 FANNIN UCT 1006 HOUSTON TX 77030 741761309 501(C)(3) 439994 0 PROGRAM SUPPORT THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON 301 UNIVERSITY BOULEVARD GALVESTON TX 77555 746000949 501(C)(3) 349822 0 PROGRAM SUPPORT THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD DALLAS TX 75390 756002868 501(C)(3) 300000 0 PROGRAM SUPPORT THE UNIVERSITY OF UTAH 201 PRESIDENTS CIRCLE SALT LAKE CITY UT 84112 876000525 501(C)(3) 149976 0 PROGRAM SUPPORT THOMAS JEFFERSON UNIVERSITY 833 CHESTNUT STREET SUITE 900 PHILADELPHIA PA 19107 231352651 501(C)(3) 136365 0 PROGRAM SUPPORT TRUSTEES OF BOSTON UNIVERSITY 85 EAST NEWTON BOSTON MA 02218 042103547 501(C)(3) 475000 0 PROGRAM SUPPORT UNIVERSITY OF ALABAMA AT BIRMINGHAM 9500 GILMAN DRIVE DEPT 0934 BIRMINGHAM AL 35294 636005396 501(C)(3) 100000 0 PROGRAM SUPPORT UNIVERSITY OF ARIZONA UNIVERSITY OF ARIZONA TUCSON AZ 85287 742652689 501(C)(3) 138324 0 PROGRAM SUPPORT UNIVERSITY OF COLORADO ANSCHUTZ 12631 EAST 17TH AVENUE BOX F496 AURORA CO 80045 846000555 501(C)(3) 173286 0 PROGRAM SUPPORT UNIVERSITY OF CONNECTICUT HEALTH CENTER 263 FARMINGTON AVE FARMINGTON CT 06030 521725543 501(C)(3) 61437 0 PROGRAM SUPPORT UNIVERSITY OF FLORIDA 207 GRINTER HALL GAINESVILLE FL 32611 596002052 501(C)(3) 624358 0 PROGRAM SUPPORT UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE INC 3901 RAINBOW BOULEVARD KANSAS CITY KS 66103 481108830 501(C)(3) 324995 0 PROGRAM SUPPORT UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 500 SOUTH LIMESTONE LEXINGTON KY 40526 616033693 501(C)(3) 299998 0 PROGRAM SUPPORT UNIVERSITY OF MARYLAND BALTIMORE 620 W LEXINGTON STREET 4TH FLOOR BALTIMORE MD 21201 526002033 501(C)(3) 377543 0 PROGRAM SUPPORT UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL 55 LAKE AVENUE NORTH WORCESTER MA 01655 043167352 501(C)(3) 474997 0 PROGRAM SUPPORT UNIVERSITY OF MIAMI 1320 S DIXIE HIGHWAY SUITE 650 CORAL GABLES FL 33146 590624458 501(C)(3) 733780 0 PROGRAM SUPPORT UNIVERSITY OF MISSOURI - ST LOUIS ONE UNIVERSITY BOULEVARD ST LOUIS MO 63121 436003859 501(C)(3) 149972 0 PROGRAM SUPPORT UNIVERSITY OF NEBRASKA MEDICAL CENTER 985100 NEBRASKA MEDICAL CENTER OMAHA NE 68198 470049123 501(C)(3) 150000 0 PROGRAM SUPPORT UNIVERSITY OF PITTSBURGH 300 MURDOCH BUILDING 3420 FORBES AVENUE PITTSBURGH PA 15260 250965591 501(C)(3) 348089 0 PROGRAM SUPPORT UNIVERSITY OF SOUTH CAROLINA 1600 HAMPTON STREET SUITE 414 COLUMBIA SC 29208 576001153 501(C)(3) 1480801 0 PROGRAM SUPPORT UNIVERSITY OF SOUTH FLORIDA 3702 SPECTRUM BLVD SUITE 165 TAMPA FL 33612 593102112 501(C)(3) 325000 0 PROGRAM SUPPORT UNIVERSITY OF SOUTHERN CALIFORNIA 3720 S FLOWER STREET 3RD FLOOR LOS ANGELES CA 90089 951642394 501(C)(3) 2948582 0 PROGRAM SUPPORT UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO 7703 FLOYD CURL DRIVE SAN ANTONIO TX 78229 741586031 501(C)(3) 863592 0 PROGRAM SUPPORT UNIVERSITY OF TEXAS RIO GRANDE VALLEY 1201 W UNIVERSITY DRIVE EDINBURG TX 78539 465292740 501(C)(3) 149985 0 PROGRAM SUPPORT UNIVERSITY OF TOLEDO HEALTH SCIENCE CAMPUS 3000 ARLINGTON AVENUE TOLEDO OH 43614 346401483 501(C)(3) 150000 0 PROGRAM SUPPORT UNIVERSITY OF VIRGINIA PO BOX 400195 CHARLOTTESVILLE VA 22904 546001796 501(C)(3) 175000 0 PROGRAM SUPPORT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE BOX 359472 SEATTLE WA 98195 916001537 501(C)(3) 440000 0 PROGRAM SUPPORT UNIVERSITY OF WISCONSIN-MADISON 21 NORTH PARK STREET SUITE 6301 MADISON WI 53715 396006492 501(C)(3) 324997 0 PROGRAM SUPPORT UNIVERSITY OF WISCONSIN-MILWAUKEE PO BOX 340 MILWAUKEE WI 53201 391805963 501(C)(3) 300000 0 PROGRAM SUPPORT VANDERBILT UNIVERSITY 110 21ST AVENUE SOUTH SUITE 800 NASHVILLE TN 37203 620476822 501(C)(3) 114289 0 PROGRAM SUPPORT VANDERBILT UNIVERSITY MEDICAL CENTER 110 21ST AVENUE SOUTH SUITE 800 NASHVILLE TN 37203 352528741 501(C)(3) 280000 0 PROGRAM SUPPORT WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD WINSTONSALEM NC 27157 223849199 501(C)(3) 7867117 0 PROGRAM SUPPORT WASHINGTON STATE UNIVERSITY 280 LIGHTY PULLMAN WA 99164 916001108 501(C)(3) 324034 0 PROGRAM SUPPORT WASHINGTON UNIVERSITY IN ST LOUIS 1054 ONE BROOKINGS DRIVE ST LOUIS MO 63130 430653611 501(C)(3) 2585618 0 PROGRAM SUPPORT WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVE NEW YORK NY 10065 131623978 501(C)(3) 140000 0 PROGRAM SUPPORT WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 455 MAIN STREET CAMBRIDGE MA 02142 061043412 501(C)(3) 175000 0 PROGRAM SUPPORT WILLIAM BEAUMONT HOSPITAL 3811 W 13 MILE RD ROYAL OAK MI 48073 381459362 501(C)(3) 10231 0 PROGRAM SUPPORT WORLD EVENTS FORUM INC 1631 WHITCOMB DES PLAINES IL 60018 364390483 30000 0 PROGRAM SUPPORT YALE UNIVERSITY PO BOX 208327 NEW HAVEN CT 06520 060646973 501(C)(3) 588766 0 PROGRAM SUPPORT 105 4 RESPITE CAREGIVER 3500 1792339 SCHOLARSHIPS 31 32341 SAFE RETURN 155 15256 PART I, LINE 2: PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. THE OVER-SIGHT OF THE SCIENTIFIC INTEGRITY OF THE ALZHEIMER'S ASSOCIATION NATIONAL AND INTERNATIONAL RESEARCH GRANT PROGRAM IS THREE-FOLD. FIRST, THE ALZHEIMER'S ASSOCIATION VOLUNTARY MEDICAL & SCIENTIFIC ADVISORY GROUP (MSAG), THE ALZHEIMER'S ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM COUNCIL, AND THE ALZHEIMER'S ASSOCIATION MEDICAL & SCIENTIFIC RELATIONS DIVISION, ENSURES PEER REVIEW AND HIGH QUALITY OF FUNDED AWARDS DURING THE GRANT REVIEW PROCESS AND DEVELOPS FOCUSED REQUESTS FOR APPLICATIONS (RFAS) BASED ON IDENTIFIED NEEDS IN THE ALZHEIMER RESEARCH COMMUNITY. SECOND, THE ALZHEIMER'S ASSOCIATION IS ENGAGED IN A PORTFOLIO ANALYSIS OF SCIENTIFIC AREAS OF INVESTMENT TO MONITOR THE DIVERSITY OF THE GRANTS PORTFOLIO, POTENTIAL GAPS IN RESEARCH FUNDING, AND POTENTIAL OVERLAP OF AREAS FUNDED. THE ANALYSIS INFORMS FUTURE FUNDING DECISIONS, STRATEGIC ACTIVITIES AND AREAS OF FUTURE RFA FOCUS. THIRD, THERE IS A DETAILED PROCESS ONCE A GRANT IS AWARDED TO MONITOR PROGRAM AND SCIENTIFIC AND FINANCIAL INTEGRITY AND, FOR THE FELLOWSHIP PROGRAM, THERE IS A MENTOR EVALUATION. THE ALZHEIMER'S ASSOCIATION MONITORS THE USE OF GRANT FUNDS BOTH INSIDE AND OUTSIDE OF THE UNITED STATES AS FOLLOWS: ALL AWARDEES ARE REQUIRED TO PROVIDE ANNUAL AND IN SOME CASES BI-ANNUAL REPORTING TO THE ALZHEIMER'S ASSOCIATION ON BOTH THE STATUS OF THE RESEARCH PROJECT AND FINANCIAL EXPENDITURES ASSOCIATED WITH THE AWARD. SEVERAL PROGRAMS ARE LEVERAGED FUNDING OPPORTUNITIES WITH PARTNER ORGANIZATIONS. THESE RESEARCH PROJECTS AND FINANCIAL EXPENDITURE REPORTS ARE SHARED BETWEEN THE PARTNER ORGANIZATION(S). SIXTY DAYS PRIOR TO THE ANNIVERSARY OF THE AWARD START DATE, AN ALZHEIMER'S ASSOCIATION GRANT SPECIALIST NOTIFIES ALL RESEARCHERS AND ALL DESIGNATED INSTITUTIONAL FINANCIAL OFFICIALS WITH FISCAL RESPONSIBILITY FOR THE AWARD OF THE REQUIRED REPORTS, WHICH INCLUDE AN INTERIM SCIENTIFIC REPORT, INTERIM FINANCIAL REPORT, DOCUMENTATION OF ANY PUBLICATIONS AS A RESULT OF ASSOCIATION FUNDING, AND ANNUAL VERIFICATION OF REQUIRED ETHICAL (ANIMAL AND HUMAN) APPROVALS. THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD CANNOT BE THE PRIMARY INVESTIGATOR OF THE PROJECT. THE ALZHEIMER'S ASSOCIATION PROVIDES A TEMPLATE FOR THE INTERIM SCIENTIFIC REPORT AND A TEMPLATE FOR THE INTERIM FINANCIAL REPORT, BOTH OF WHICH ARE AVAILABLE FOR DOWNLOAD BY THE RESEARCHERS AS WELL AS THE OFFICIAL WITH FISCAL RESPONSIBILITY FOR THE GRANT AT THE AWARDED INSTITUTION AT HTTPS://PROPOSALCENTRAL.COM/. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WITH FISCAL RESPONSIBILITY, AND ALL REPORTS MUST BE UPLOADED BY THE AWARD RECIPIENT TO PROPOSALCENTRAL. AFTER RECEIPT, ALL FINANCIAL REPORTS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANT SPECIALIST FOR ACCURACY AND CONSISTENCY WITH THE AGREED UPON BUDGET. IN ADDITION, THE ASSOCIATION REQUIRES PROTOCOL CONTINUATION APPROVAL (I.E., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCAL (RDNA)) ANNUALLY, IF APPLICABLE FOR THE RESEARCH PROJECT. ANY SUBSEQUENT PAYMENTS TO GRANT AWARDEES ARE GENERATED AFTER THE RECEIPT OF THESE DOCUMENTS AND APPROVAL BY THE CHIEF SCIENCE OFFICER, MEDICAL AND SCIENTIFIC RELATIONS. AT THE CONCLUSION OF THE AWARD, ALL REPORTS/PUBLICATION(S) ARE DUE 90 DAYS AFTER THE AWARD EXPIRES AND MUST BE UPLOADED TO THE PROPOSALCENTRAL ONLINE SYSTEM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD. PUBLICATION(S) AS ACCEPTED ARE UPLOADED TO PROPOSALCENTRAL DURING AND AFTER THE DURATION OF THE GRANT. IT IS EXPECTED THAT AWARDEES WILL CONTINUE TO MAINTAIN RECORD OF ANY PUBLICATION(S) ACKNOWLEDGING THE ALZHEIMER'S ASSOCIATION. DATA GENERATED AS A RESULT OF ALZHEIMER'S ASSOCIATION FUNDED WORK IS SUBJECT TO DATA SHARING, AS A CONDITION OF AWARD. DATA AND OTHER OUTPUTS OF THE PROJECT ARE SUBJECTED TO THIS POLICY FOR QUICK, REASONABLE SUBMISSIONS FOR COMPLETED WORK. FURTHER, AWARDEES HAS OPPORTUNITY TO SUBMIT/SHARE DATA, AS APPLICABLE, THROUGH THE GLOBAL ALZHEIMER'S ASSOCIATION INTERACTIVE NETWORK (GAAIN*), A GLOBAL INFRASTRUCTURE CONNECTING RESEARCH STUDIES FROM AROUND THE WORLD THROUGH ONE PORTAL WHERE DATA CAN BE INTERROGATED IN AGGREGATE FOR ANALYSIS USING A VIRTUAL MACHINE. GAAIN IS WHOLLY FUNDED BY THE ALZHEIMER'S ASSOCIATION. IN ADDITION, THE ASSOCIATION REQUESTS, MONITORS, AND FOLLOWS-UP TO ENSURE SUBMISSION COMPLIANCE ON ALL AWARDED GRANTS AND THAT FINANCIAL REPORTING REQUIREMENTS ARE MET. AWARDEES' FINANCIAL REPORTS ARE REVIEWED ANNUALLY TO ENSURE ELIGIBILITY FOR CONTINUED FUNDING. DELINQUENT REPORT(S) MAY RESULT IN THE WITHDRAWAL OF FUNDING. RESEARCHERS ARE INFORMED THAT DELINQUENT REPORTING COULD LEAD TO WITHDRAWAL OF FUNDING WHEN THE REQUEST FOR ANNUAL REPORT(S) IS SENT. IF FUNDING IS WITHDRAWN DUE TO DELINQUENT REPORTS, ANY UNSPENT FUNDS MUST BE RETURNED TO THE ALZHEIMER'S ASSOCIATION. FOR-PROFIT ORGANIZATIONS ARE NOT ELIGIBLE TO APPLY TO THE ALZHEIMER'S ASSOCIATION'S INTERNATIONAL RESEARCH GRANT PROGRAM, WITH THE EXCEPTION OF THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT, ALZHEIMER'S INNOVATION AWARD AND CERTAIN PARTNERSHIP PROGRAMS, INCLUDING BIOMARKERS ACROSS NEURODEGENERATIVE DISEASES (BAND) AND TAU PIPELINE ENABLING PROGRAM (T-PEP). ELIGIBILITY OF ORGANIZATIONS APPLICABLE FOR A PROGRAM ARE DETAILED IN THAT PROGRAM'S RFA. UNLESS OTHERWISE STATED IN PROGRAM, ALL INSTITUTIONS ARE REQUIRED TO SUBMIT VERIFICATION OF THEIR NON-PROFIT STATUS DATED WITHIN THE LAST FIVE YEARS (E.G., IRS TAX DETERMINATION LETTER). IF THE IRS DETERMINATION LETTER IS DATED PRIOR TO THIS FIVE YEAR PERIOD, THE INSTITUTION IS REQUIRED TO PROVIDE DOCUMENTATION FROM AN AUTHORIZED SIGNING OFFICIAL IN THEIR GRANTS AND CONTRACTS OFFICE OR OFFICE OF SPONSORED RESEARCH TO CONFIRM THERE HAS NOT BEEN A STATUS CHANGE FOR THE ORGANIZATION. FOR THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT PROGRAM AND OTHER PROGRAMS WITH FOR-PROFIT AWARDEES, ANY FOR-PROFIT APPLICANT IS REQUIRED TO SUBMIT THE ORGANIZATION'S FINANCIAL STATEMENTS. AS PART OF THE APPLICATION PROCESS, APPLICANTS ARE REQUIRED TO UPLOAD A W-9 FORM THAT HAS BEEN DATED AND SIGNED BY AN AUTHORIZED SIGNING OFFICIAL. THIS FORM VERIFIES THAT AN INSTITUTION OR ORGANIZATION IS DESIGNATED AS A 501(C)(3) OR OTHER NON-PROFIT ENTITY. FOR PROFIT ORGANIZATIONS MUST SUBMIT DOCUMENTATION OF NET ASSETS AND ANNUAL EARNINGS, IN ADDITION TO THE W-9 FORM FOR CONSIDERATION. THESE FORMS ARE UPLOADED WITHIN THEIR SUBMITTED APPLICATION TO PROPOSALCENTRAL. AFTER RECEIPT, THESE FORMS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANT SPECIALIST. FOLLOWING REVIEW BY A GRANT SPECIALIST, APPLICATIONS ARE THEN MOVED FORWARD TO PEER-REVIEW. IF AWARDED, THE ALZHEIMER'S ASSOCIATION GRANT SPECIALIST INCLUDES THE APPROPRIATE FORMS IN PAYMENT REQUESTS FOR GRANT FUNDING PAYMENTS. PRIOR TO AWARD CONFIRMATION, THE MEDICAL AND SCIENTIFIC RELATIONS DIVISION VERIFIES THAT EACH INSTITUTION IS COMPLIANT WITH THE U.S. PATRIOT ACT AND DOES NOT APPEAR ON THE SPECIALLY DESIGNATED NATIONALS (SDN) LISTS (THROUGH OFAC). PRIOR TO PAYMENT, EACH FUNDED ALZHEIMER'S ASSOCIATION GRANT AWARDEE (I.E. THE INSTITUTION) IS VERIFIED FOR COMPLIANCE WITH THE U.S. PATRIOT ACT. THE GRANT SPECIALIST CONFIRMS ELIGIBILITY AND PROVIDES THIS DOCUMENTATION TO THE GRANT ONLINE FILE AT PROPOSALCENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WOULD IMMEDIATELY BE REPORTED TO THE ALZHEIMER'S ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. FOR TRANSACTIONS UNRELATED TO THE INTERNATIONAL RESEARCH GRANT PROGRAM IN THE MEDICAL AND SCIENTIFIC DEPARTMENT, THE SAME FINANCIAL DOCUMENTATION IS REVIEWED. THE ALZHEIMER'S ASSOCIATION MONITORS THE SCIENTIFIC ADVANCES OF THE ASSOCIATION'S GRANT AWARDEES BY MAINTAINING RECORDS OF PUBLICATIONS, PRESENTATIONS, AND INTELLECTUAL PROPERTY THAT RESULT FROM FUNDED STUDIES. THE ASSOCIATION REQUIRES THE GRANT RECIPIENT TO NOTIFY THE ALZHEIMER'S ASSOCIATION ON AN ANNUAL BASIS WITH UPDATES TO THESE RECORDS. FOLLOW-ON FUNDING FROM FEDERAL AGENCIES IS ALSO MONITORED. THE ALZHEIMER'S ASSOCIATION GRANTED FUNDS TO ALZHEIMER'S IMPACT MOVEMENT (AIM) FOR PUBLIC POLICY DIVISION ACTIVITIES IN FISCAL YEAR 2022 TO SUPPORT PRIORITIES IDENTIFIED IN THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN. THIS GRANT IS RESTRICTED TO THE FOLLOWING 501(C)(3) ACTIVITIES AND THE ANCILLARY ACTIVITIES NECESSARY TO ACCOMPLISH SPECIFIC GOALS INCLUDING: IMPLEMENTATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (RECOGNIZING THIS GROWING ALZHEIMER'S CRISIS, CONGRESS UNANIMOUSLY PASSED AND THE PRESIDENT SIGNED INTO LAW THE NATIONAL ALZHEIMER'S PROJECT ACT - NAPA); INCREASING THE COMMITMENT TO ALZHEIMER'S RESEARCH; EXPANDING EDUCATION EFFORTS AND CAREGIVER SUPPORT SERVICES; EXPANDING DIAGNOSIS AND PLANNING. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. PART III: THE ASSOCIATION PROVIDES RESPITE CAREGIVER ASSISTANCE TO INDIVIDUALS FOR THE BENEFIT OF SPECIFIED INDIVIDUALS TO COVER CARETAKING COSTS. THE ASSOCIATION DOES NOT KEEP A RECORD TO TRACK EACH GRANT GIVEN TO EVERY SINGLE INDIVIDUAL, SO THEY ARE USING AN ESTIMATE FOR THE NUMBER OF RECIPIENTS BASED ON CURRENT DATA AVAILABLE AT THIS TIME. X 1 1 X X X X X 0 1 0 0 0 0 0 1 0 HARRY JOHNS PRESIDENT (THRU 11/2021)/CEO 823841 22318 388300 0 3766 0 203259 0 26650 0 1445816 22318 0 0 KATHERINE JOANNE PIKE CSO/PRESIDENT (AS OF 11/2021) 558167 2286 165500 0 1549 0 71917 0 33170 0 830303 2286 0 0 DONNA MCCULLOUGH - CHIEF MISSION & FIELD OPERATIONS OFFICER 535532 328 154400 0 2923 0 69595 0 12397 0 774847 328 0 0 RICHARD HOVLAND COO, CFO, & ASST. TREASURER 495057 632 149700 0 3757 0 69400 0 27345 0 745259 632 0 0 MARIA CARRILLO CHIEF SCIENCE OFFICER 468610 0 140446 0 823 0 65610 0 34892 0 710381 0 0 0 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 425538 16233 133631 0 804 0 63614 0 33198 0 656785 16233 0 0 GLENDA BERRY WEST AREA LEADER 384664 0 115929 0 2179 0 59378 0 23817 0 585967 0 0 0 KENANN CASSIDY EAST AREA LEADER 386870 0 115229 0 5500 0 59378 0 15930 0 582907 0 0 0 MICHELLE HELTON - FORMER CFO (THRU 5/21)/ VP, FINANCIAL OPS. 312360 0 100276 0 1873 0 31900 0 35732 0 482141 0 0 0 CHRISTINE FOH - ASST SECY VP LEGAL & GC (THRU 11/2021) 325575 0 45748 0 2913 0 20265 0 1748 0 396249 0 0 0 PART I, LINE 1A TRAVEL FOR COMPANIONS AT TIMES A BOARD MEMBER WITH EARLY ONSET ALZHEIMER'S DISEASE MAY REQUIRE A COMPANION TO ACCOMPANY HIM OR HER ON BUSINESS TRAVEL FOR SAFETY REASONS. SINCE HIS OR HER INVOLVEMENT IN THE MEETINGS IS CRITICAL TO REPRESENTING KEY CONSTITUENTS AND APPROPRIATELY FULFILLING THE MISSION OF THE ALZHEIMER'S ASSOCIATION, THE EXPENSES OF COMPANION TRAVEL ARE REIMBURSED. PART I, LINE 4B SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN THERE WERE NO ADDITIONAL AMOUNTS ACCRUED OR REPORTED FOR HARRY JOHNS, RICHARD HOVLAND, OR DONNA MCCULLOUGH RELATED TO A 457(B) PLAN IN CALENDAR YEAR 2021. ALZHEIMER'S ASSOCIATION ESTABLISHED A SECTION 457(F) PLAN FOR CERTAIN MEMBERS OF SENIOR MANAGEMENT. ACCORDING TO THE 457(F) PLAN, AMOUNTS ARE CONTRIBUTED ON BEHALF OF PARTICIPANTS (AS DETERMINED BY THE BOARD) FOR EACH PLAN YEAR. THE PLAN IS INTENDED TO SUPPLEMENT OTHER RETIREMENT PLANS (QUALIFIED PLANS, SOCIAL SECURITY AND THE 457(B) PLAN) TO ACHIEVE AN INCOME REPLACEMENT RATIO. THE ONLY PARTICIPANTS OF THE PLAN ARE THE BELOW INDIVIDUALS ALONG WITH THEIR CONTRIBUTIONS FOR 2021: - MARIA CARRILLO - $33,710 - ROBERT EGGE - $31,714 - DONNA MCCULLOUGH - $37,695 - KENANN CASSIDY - $27,478 - GLENDA BERRY - $27,478 - JOANNE PIKE - $40,017 THE ABOVE AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN C, RETIREMENT AND OTHER DEFERRED COMPENSATION. NONE OF THE PARTICIPANTS ABOVE HAVE VESTED IN ANY OF THE SERP BENEFITS. THE FIRST VESTING WILL OCCUR ON DECEMBER 31, 2022. PART II, COLUMN (B) (II): SUPPLEMENTAL COMPENSATION INFORMATION: BONUS AND INCENTIVE COMPENSATION HARRY JOHNS RECEIVED PERFORMANCE BASED INCENTIVE COMPENSATION OF $388,300 BASED ON HIS SUCCESSFUL ACHIEVEMENT OF SPECIFIC GOALS, WHICH WERE DEVELOPED, REVIEWED, AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS IN CONSULTATION WITH THE BOARD'S INDEPENDENT THIRD-PARTY COMPENSATION CONSULTANTS. THIS PERFORMANCE BASED INCENTIVE COMPENSATION WAS EARNED FOR PERFORMANCE IN FISCAL YEAR 2021 AND WAS PAID IN CALENDAR YEAR 2021. RICHARD HOVLAND, JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, MICHELLE HELTON, GLENDA BERRY, KENANN CASSIDY AND CHRISTINE FOH RECEIVED PERFORMANCE BASED INCENTIVES EARNED IN FISCAL YEAR 2021 AND PAID IN CALENDAR YEAR 2021. PART II, COLUMN (B) (III): HARRY JOHNS AND RICHARD HOVLAND RECEIVE A BASIC LIFE INSURANCE BENEFIT OF ONE TIMES THE ANNUAL SALARY. THE AMOUNT REPRESENTED IN THIS SECTION IS IMPUTED INCOME FOR THE GROUP TERM LIFE BENEFIT. JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, MICHELLE HELTON AND CHRISTINE FOH ALSO RECEIVE THE LIFE INSURANCE BENEFIT. HARRY JOHNS, RICHARD HOVLAND, JOANNE PIKE, DONNA MCCULLOUGH, KENANN CASSIDY AND CHRISTINE FOH HAVE ADDITIONAL IMPUTED INCOME FOR VOLUNTARY ELECTIONS UNDER THE GROUP DISABILITY PLAN. PART II, COLUMN (C): SUPPLEMENTAL COMPENSATION INFORMATION: RETIREMENT AND OTHER DEFERRED COMPENSATION HARRY JOHNS - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED BROAD-BASED 401(K) RETIREMENT PLAN -$31,900 RICHARD HOVLAND - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN - $31,900 JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, MICHELLE HELTON AND CHRISTINE FOH - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN. JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY - RETIREMENT AND OTHER DEFERRED COMPENSATION ALSO INCLUDES EMPLOYER CONTRIBUTIONS TO A NON-QUALIFIED 457(F) SUPPLEMENTAL RETIREMENT PLAN. PART II, COLUMN (D): SUPPLEMENTAL COMPENSATION INFORMATION: NONTAXABLE BENEFITS HARRY JOHNS - NON-TAXABLE BENEFITS OF $26,649.87 INCLUDE EMPLOYER CONTRIBUTIONS TO MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON HIS PERSONAL ELECTIONS FOR CALENDAR YEAR 2021 THROUGH THE BENEFIT OFFERINGS AVAILABLE TO ALL OTHER BENEFITS-ELIGIBLE EMPLOYEES AT OUR ORGANIZATION. THE AMOUNTS REPRESENTED FOR RICHARD HOVLAND, JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, MICHELLE HELTON, GLENDA BERRY, KENANN CASSIDY AND CHRISTINE FOH REPRESENT COMPANY CONTRIBUTIONS TO THE MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON INDIVIDUAL ELECTIONS. PART I, LINE 7 ALZHEIMER'S ASSOCIATION HAS A PERFORMANCE-BASED INCENTIVE COMPENSATION PLAN. CERTAIN INDIVIDUALS OF ALZHEIMER'S ASSOCIATION CAN EARN INCENTIVE COMPENSATION IF THEY MEET THE CRITERIA OUTLINED IN THEIR RESPECTIVE EMPLOYMENT AGREEMENTS. THE CEO IS ALSO ELIGIBLE TO PARTICIPATE IN THE INCENTIVE COMPENSATION PLAN AND HIS INCENTIVE COMPENSATION PAYMENTS ARE REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE RETAINS SOLE DISCRETION TO DETERMINE THE AMOUNT OF ANY INCENTIVE COMPENSATION PAID TO EXECUTIVES. SARA GIAMMARISE DAUGHTER OF DAVID HUNTER, DIRECTOR 61920 EMPLOYMENT 0 RAZA LAMB SON OF BRUCE LAMB, DIRECTOR 24889 EMPLOYMENT 0 X 671 21261922 FMV X NON GALA-RLTD 38 422491 FMV X GALA-RELATED 119 414948 FMV X CRYPTO CURREN 15 347001 FMV X FUNDRAISING 1 250000 FMV X RAFFLE 4 19263 FMV 3 0 1 1 PART I, LINE 25 AND LINE 32B: THIRD PARTY ASSISTANCE OF NONCASH CONTRIBUTIONS LINE 25: THE ALZHEIMER'S ASSOCIATION RECEIVES VARIOUS NONCASH CONTRIBUTIONS FOR THEIR FUNDRAISING EVENTS. THESE ITEMS INCLUDE SPORTING TICKETS, JEWELRY, CONCERT TICKETS, DINNERS AND VARIOUS OTHER PACKAGES. LINE 32B: A THIRD PARTY RECEIVES DIRECTLY, SELLS AND REMITS PROCEEDS FROM AUTOMOBILE SALES. PART I, COLUMN B: ALZHEIMER'S ASSOCIATION IS REPORTING THE DOLLAR AMOUNT OF NONCASH CONTRIBUTIONS AS WELL AS THE NUMBER OF ITEMS RECEIVED. FORM 990, PART III, LINE I, DESCRIPTION OF ORGANIZATION MISSION: (MISSION CONTINUED) AND EARLY DETECTION, AND MAXIMIZING QUALITY CARE AND SUPPORT. THE ALZHEIMER'S ASSOCIATION IS A VALUED RESOURCE FOR CAREGIVERS AND THOSE LIVING WITH THE DISEASE, OFFERING INFORMATION, EDUCATION AND SUPPORT. APPROXIMATELY 207 OFFICES ACROSS THE U.S. ARE DOING BUSINESS AS THE ALZHEIMER'S ASSOCIATION AND VARIOUS NAMES AS A COLLECTION OF 75 CHAPTERS WORKING TO ACCOMPLISH THE MISSION. THE ORGANIZATION IS HEADQUARTERED IN CHICAGO, AND HAS A PUBLIC POLICY OFFICE IN WASHINGTON, D.C. THE ALZHEIMER'S ASSOCIATION PROVIDES 24/7 CONSTITUENT SUPPORT IN OVER 170 LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE 365 DAYS A YEAR (1-800-272-3900) AS WELL AS ON OUR WEBSITE, ALZ.ORG*. AS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN CARE, SUPPORT AND RESEARCH, SINCE AWARDING THE FIRST GRANTS IN 1982, THE ASSOCIATION HAS COMMITTED MORE THAN $475 MILLION TO MORE THAN 3,000 BEST-OF-FIELD GRANTS. AS A LEADER IN THE FIELD, THE ALZHEIMER'S ASSOCIATION FOSTERS COLLABORATION OF THE SCIENTIFIC COMMUNITY BY HOSTING THE LARGEST INTERNATIONAL CONFERENCE FOCUSING ON ALZHEIMER'S DISEASE RESEARCH IN THE WORLD. IN ADDITION, THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S, THEIR FAMILIES AND CAREGIVERS, SPEAKING UP TO HELP ENCOURAGE CONGRESS TO TAKE ACTION IN THE FIGHT AGAINST THIS DISEASE, (INCLUDING THROUGH AN ANNUAL ADVOCACY FORUM IN WASHINGTON, D.C.) AND LEADS ADVOCACY EFFORTS IN EVERY STATE. CONCERN ABOUT ALZHEIMER'S DISEASE AND AWARENESS ABOUT THE ASSOCIATION ARE CRITICAL TO ACCELERATING PROGRESS. THE ALZHEIMER'S ASSOCIATION STRIVES TO MAKE MORE PEOPLE AWARE OF THE SERVICES AVAILABLE FOR THOSE FACING THIS DISEASE AND THE BENEFITS OF EARLY DETECTION. (MORE THAN 5 MILLION ALZHEIMER'S ASSOCIATION CONSTITUENTS HAVE SIGNED UP TO EDUCATE, ADVOCATE, DONATE, AND PARTICIPATE TO MOVE THIS CAUSE FORWARD). A DONOR-SUPPORTED ORGANIZATION, THE ALZHEIMER'S ASSOCIATION ALLOCATES ITS FUNDS IN AN ETHICAL AND RESPONSIBLE MANNER THAT EXCEEDS THE RIGOROUS STANDARDS OF AMERICA'S MOST EXPERIENCED CHARITY EVALUATOR, THE BETTER BUSINESS BUREAU WISE GIVING ALLIANCE. THE ASSOCIATION IS QUALIFIED TO USE THE "BBB TORCH LOGO AND A NATIONAL CHARITY SEAL ("SEAL"). * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 1A GOVERNING BODY: THE BOARD OF DIRECTORS OF THE ALZHEIMER'S ASSOCIATION IS THE ORGANIZATION'S GOVERNING BODY. THE BOARD HAS DELEGATED AUTHORITY TO ITS STANDING AND OTHER BUSINESS COMMITTEES AS DESCRIBED IN ARTICLE VII OF THE ORGANIZATIONAL BYLAWS. THE FOLLOWING EXCERPT FROM THE ASSOCIATION'S BYLAWS DISCUSS COMMITTEES OF THE BOARD OF DIRECTORS. COMMITTEES OF DIRECTORS: ALL COMMITTEE MEETINGS SHALL BE OPEN TO ATTENDANCE BY ALL DIRECTORS EXCEPT IN EXECUTIVE SESSION. ONLY COMMITTEE MEMBERS MAY VOTE ON COMMITTEE MATTERS. THE BOARD OF DIRECTORS SHALL HAVE THE FOLLOWING STANDING COMMITTEES: EXECUTIVE, FINANCE, GOVERNANCE AND NOMINATING, COMPENSATION, AUDIT AND MISSION OUTCOMES. EXECUTIVE COMMITTEE: THE EXECUTIVE COMMITTEE SHALL MANAGE THE BUSINESS AND PROPERTY OF THE ASSOCIATION IN BETWEEN MEETINGS OF THE BOARD OF DIRECTORS; PROVIDED, THAT THE EXECUTIVE COMMITTEE SHALL NOT TAKE ANY ACTION WHICH IS CONTRARY TO POLICIES OF THE ASSOCIATION AS ADOPTED BY THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL HAVE SUCH ADDITIONAL POWERS AS MAY BE PROVIDED BY LAW OR RESOLUTION OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL REPORT TO THE BOARD OF DIRECTORS AT EACH MEETING OF THE BOARD OF DIRECTORS AND REPORT EXECUTIVE COMMITTEE ACTIONS IN A TIMELY MANNER IN BETWEEN BOARD OF DIRECTORS MEETINGS. AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT AN EXECUTIVE COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN DIRECTORS. THE CHAIR, CHAIR ELECT, VICE CHAIRS, SECRETARY, TREASURER, CHAIRS OF THE STANDING COMMITTEES, AND THE CHAIR OF THE MEDICAL AND SCIENTIFIC ADVISORY GROUP, SHALL BE MEMBERS OF THE EXECUTIVE COMMITTEE. THE CHAIR OF THE BOARD OF DIRECTORS SHALL BE THE CHAIR OF THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE MAY HOLD REGULAR MEETINGS MONTHLY OR AS IT MAY OTHERWISE DETERMINE, AT SUCH PLACE AND AT SUCH TIMES AND UPON SUCH NOTICE AS IT MAY DETERMINE. SPECIAL MEETINGS OF THE EXECUTIVE COMMITTEE MAY BE CALLED AT ANY TIME BY THE CHAIR OR BY ANY THREE OF ITS MEMBERS, BY NOTICE DELIVERED PERSONALLY OR BY MAIL, TELEPHONE, ELECTRONIC MAIL OR FACSIMILE AT LEAST SEVEN DAYS (OR AT LEAST 48 HOURS IN THE CASE OF TELEPHONIC MEETINGS) PRIOR TO THE MEETING. A MAJORITY OF THE CURRENTLY SERVING MEMBERS OF THE EXECUTIVE COMMITTEE SHALL CONSTITUTE A QUORUM FOR ALL PURPOSES. FINANCE COMMITTEE: THE FINANCE COMMITTEE SHALL CONSIST OF AT LEAST FIVE DIRECTORS AND SHALL BE CHAIRED BY THE TREASURER. THE FINANCE COMMITTEE SHALL OVERSEE AND REVIEW ALL FINANCIAL REPORTS, ACCOUNTING ACTIVITIES AND INVESTMENT DECISIONS OF THE ASSOCIATION AND ALSO SHALL RECOMMEND A PROJECTED BUDGET FOR EACH FISCAL YEAR TO BE PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL. THE FINANCE COMMITTEE AND THE COMPENSATION COMMITTEE SHALL HAVE SEPARATE BUT COORDINATED FIDUCIARY AND OVERSIGHT RESPONSIBILITY WITH RESPECT TO THE ALZHEIMER'S ASSOCIATION 401(K) SAVINGS PLAN AND ANY OTHER TAX-QUALIFIED RETIREMENT PLANS SPONSORED BY THE ASSOCIATION (THE "PLANS"). WORKING IN COORDINATION WITH THE COMPENSATION COMMITTEE, THE FINANCE COMMITTEE SHALL BE RESPONSIBLE FOR PROVIDING APPROPRIATE GOVERNANCE OVERSIGHT AS TO THE FINANCIAL AND INVESTMENT OPERATIONS OF THE PLANS, INCLUDING APPOINTMENT OF FIDUCIARIES RELATING TO INVESTMENT MANAGEMENT UNDER THE PLANS, FOR TAKING FINAL ACTIONS WITH RESPECT TO SUCH FINANCIAL AND INVESTMENT OPERATIONS, AND FOR PROVIDING APPROPRIATE REPORTS TO THE BOARD OF DIRECTORS WITH RESPECT TO SUCH OVERSIGHT AND ACTIONS. GOVERNANCE AND NOMINATING COMMITTEE: AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT A GOVERNANCE AND NOMINATING COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN INDIVIDUALS CURRENTLY SERVING AS A DIRECTOR. AT LEAST ONE-THIRD OF THE GOVERNANCE AND NOMINATING COMMITTEE SHALL BE DIRECTORS HAVING CHAPTER EXPERIENCE. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL ASSIST THE BOARD IN ENSURING THE SUCCESSFUL GOVERNANCE OF THE ASSOCIATION THROUGH BOARD ASSESSMENT, RECRUITMENT, NOMINATIONS, ORIENTATION AND DEVELOPMENT. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL NOMINATE CANDIDATES FOR DIRECTORS, OFFICERS AND MEMBERS OF THE EXECUTIVE COMMITTEE. THE GOVERNANCE AND NOMINATING COMMITTEE MAY NOMINATE CANDIDATES FOR HONORARY DIRECTOR AND ANY ADVISORY OR HONORARY COUNCILS, GROUPS OR COMMITTEES AND APPROVE THE CANDIDATES FOR MEDICAL AND SCIENTIFIC ADVISORY GROUP MEMBERSHIP. THE GOVERNANCE AND NOMINATING COMMITTEE ALSO SHALL PROVIDE INPUT TO THE CHAIR ON THE SELECTION OF VICE CHAIRS AND COMMITTEE CHAIRS. COMPENSATION COMMITTEE: THE COMPENSATION COMMITTEE SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING, SUBJECT TO FURTHER AND FINAL APPROVAL BY THE BOARD OF DIRECTORS, ALL FORMS OF COMPENSATION AND BENEFITS FOR THE PRESIDENT OR CHIEF EXECUTIVE OFFICER. THE COMPENSATION COMMITTEE SHALL CONDUCT ITS REVIEW AND APPROVAL OF HIS OR HER TOTAL COMPENSATION AND BENEFITS IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED ("SECTION 4958"). THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING APPROPRIATE MARKET DATA, TO BE USED BY THE PRESIDENT OR CHIEF EXECUTIVE OFFICER TO SET OR ADJUST COMPENSATION OF ANY OTHER EXECUTIVE-LEVEL EMPLOYEE WHO COULD BE CONSIDERED TO BE IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER THE AFFAIRS OF THE ASSOCIATION WITHIN THE MEANING OF SECTION 4958. THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR OVERSIGHT OF EXECUTIVE-LEVEL BENEFITS AND SUCCESSION PLANNING FOR KEY POSITIONS IN THE ASSOCIATION. THE COMPENSATION COMMITTEE AND THE FINANCE COMMITTEE SHALL HAVE SEPARATE BUT COORDINATED FIDUCIARY AND OVERSIGHT RESPONSIBILITY WITH RESPECT TO THE ALZHEIMER'S ASSOCIATION 401(K) SAVINGS PLAN AND ANY OTHER TAX-QUALIFIED RETIREMENT PLANS SPONSORED BY THE ASSOCIATION (THE "PLANS"). WORKING IN COORDINATION WITH THE FINANCE COMMITTEE, THE COMPENSATION COMMITTEE SHALL BE RESPONSIBLE FOR PROVIDING APPROPRIATE GOVERNANCE OVERSIGHT AS TO THE ADMINISTRATIVE OPERATIONS OF THE PLANS, INCLUDING APPOINTMENT OF FIDUCIARIES RELATING TO ADMINISTRATIVE MANAGEMENT UNDER THE PLANS, FOR TAKING FINAL ACTIONS WITH RESPECT TO SUCH ADMINISTRATIVE OPERATIONS, AND FOR PROVIDING APPROPRIATE REPORTS TO THE BOARD OF DIRECTORS WITH RESPECT TO SUCH OVERSIGHT AND ACTIONS. AUDIT COMMITTEE: THE AUDIT COMMITTEE SHALL BE RESPONSIBLE FOR RECOMMENDING AN AUDITOR TO THE BOARD OF DIRECTORS AND SHALL OVERSEE THE ACTIVITIES OF ANY INTERNAL AUDITOR OF THE ASSOCIATION. THE AUDIT COMMITTEE SHALL SEE THAT AN ANNUAL AUDIT IS PREPARED BY AN INDEPENDENT FIRM OF CERTIFIED PUBLIC ACCOUNTANTS SELECTED BY THE BOARD OF DIRECTORS AND, UPON RECEIVING SUCH AUDITOR'S REPORT, THE AUDIT COMMITTEE SHALL PREVIEW THE AUDIT REPORT FOR SUBMISSION TO THE BOARD OF DIRECTORS EACH YEAR. THE AUDIT COMMITTEE SHALL REVIEW THE FINANCIAL REPORTS OF THE ASSOCIATION, ITS SYSTEM OF INTERNAL CONTROLS, AND THE AUDIT PROCESS. THE AUDIT COMMITTEE SHALL HAVE AT LEAST FIVE MEMBERS, ALL OF WHOM ARE MEMBERS OF THE BOARD OF DIRECTORS AND THE MAJORITY OF WHOM HAVE APPROPRIATE FINANCIAL EXPERTISE. AT LEAST ONE MEMBER OF THE AUDIT COMMITTEE SHALL MEET THE REQUIREMENT OF "AUDIT COMMITTEE FINANCIAL EXPERT" AS THEN DEFINED BY THE SECURITIES AND EXCHANGE COMMISSION. THE MAJORITY OF THE MEMBERS OF THE AUDIT COMMITTEE MAY NOT CONCURRENTLY SERVE ON THE FINANCE COMMITTEE AND THE TREASURER AND CHAIR OF THE FINANCE COMMITTEE MAY NOT SERVE CONCURRENTLY ON THE AUDIT COMMITTEE. MISSION OUTCOMES COMMITTEE: THE MISSION OUTCOMES COMMITTEE SHALL OVERSEE AND REVIEW PROGRESS AGAINST THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN'S PRIORITY ACTIVITIES AND SHALL SUPPORT AND FACILITATE BOARD OF DIRECTORS CONVERSATIONS THAT ARE FOCUSED ON MISSION DELIVERY AND THE APPROVED STRATEGIC PLAN. OTHER COMMITTEES: IN ADDITION TO THE STANDING COMMITTEES, OTHER COMMITTEES MAY BE DESIGNATED BY RESOLUTION ADOPTED BY A MAJORITY OF THE DIRECTORS PRESENT AT ANY MEETING. FORM 990, PART VI, SECTION A, LINE 4 CHANGES TO ORGANIZATIONAL DOCUMENTS THE ORGANIZATION AMENDED ITS BYLAWS ON OCTOBER 16, 2021, TO ALLOW FOR THE ROLES OF PRESIDENT AND CEO, HISTORICALLY HELD BY THE SAME PERSON, TO BE HELD BY SEPARATE INDIVIDUALS. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE ORGANIZATION UNDERGOES A THOROUGH REVIEW PROCESS BEFORE FILING THE RETURN. THE AUDIT COMMITTEE DISCUSSES AND REVIEWS THE FORM BEFORE IT IS PROVIDED TO THE OFFICERS AND FULL BOARD OF DIRECTORS. ALL OFFICERS AND THE FULL BOARD OF DIRECTORS ARE PROVIDED A COPY FOR THEIR REVIEW AND HAVE THE OPPORTUNITY TO COMMENT BEFORE THE FORM 990 IS FILED. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT THE ALZHEIMER'S ASSOCIATION CONFLICT OF INTEREST POLICY IS DESCRIBED IN ARTICLE XII, SECTION 2 OF THE ORGANIZATIONAL BYLAWS. THE RESPONSIBILITY FOR DISCLOSING ANY KNOWN OR REASONABLY FORESEEABLE ACTUAL OR POTENTIAL CONFLICTS OF INTEREST SHALL BE DISCLOSED TO THE BOARD OF DIRECTORS OR ITS COMMITTEE DESIGNEE BY THE INTERESTED PERSON WHOSE INTERESTS ARE OR MAY APPEAR TO BE IN CONFLICT WITH THE ASSOCIATION. ALL INTERESTED PERSONS ARE REQUIRED TO FILE WITH THE ASSOCIATION A DISCLOSURE STATEMENT PRIOR TO SUCH INDIVIDUAL COMMENCING HIS OR HER SERVICE WITH THE ASSOCIATION AND AT SUCH TIME AND IN SUCH MANNER AS MAY BE PROVIDED IN GUIDELINES ADOPTED BY THE BOARD OF DIRECTORS. ALL INTERESTED PERSONS SERVING THE ASSOCIATION SHALL FILE DISCLOSURE STATEMENTS, FROM TIME TO TIME, AS MAY BE REQUIRED BY THE BOARD OF DIRECTORS, THE BYLAWS ARTICLE XI, SECTION 2 OR ANY OTHER BOARD POLICY, AND IN NO EVENT LESS OFTEN THAN ANNUALLY. INTERESTED PERSONS SHALL DISCLOSE ANY CONFLICT AND SHALL NOT VOTE ON A MATTER AND FURTHER IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. THE MINUTES SHALL REFLECT THAT THE CONFLICT OF INTEREST WAS DISCLOSED AND THE INTERESTED PERSON DID NOT PARTICIPATE IN ANY DISCUSSION OF THE MATTER AND DID NOT VOTE ON THE MATTER IN PERSON OR BY PROXY. WHEN ANY SUCH CONFLICT OF INTEREST IS RELEVANT TO A MATTER REQUIRING ACTION BY THE BOARD OF DIRECTORS OR ANY COMMITTEE OF THE BOARD, THE INTERESTED PERSON SHALL DISCLOSE SUCH CONFLICT TO THE BOARD OF DIRECTORS OR SUCH COMMITTEE AND SHALL NOT VOTE ON THE MATTER. FURTHER THE INTERESTED PERSON OR REPRESENTATIVE HAVING A CONFLICT IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR THE COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. WHEN THERE IS A DOUBT AS TO WHETHER A CONFLICT OF INTEREST EXISTS, THE MATTER SHALL BE RESOLVED BY A VOTE OF THE BOARD OF DIRECTORS OR THE COMMITTEE, AS THE CASE MAY BE, EXCLUDING THE INTERESTED PERSON CONCERNING WHOM THE DOUBT HAS ARISEN. COPIES OF THE ASSOCIATION BYLAWS ARTICLE, INCLUDING THE CONFLICT OF INTEREST POLICY AND ANY RELATED ETHICAL POLICY OR GUIDELINES AS FROM TIME TO TIME ADOPTED OR AMENDED BY THE BOARD OF DIRECTORS, SHALL BE PRESENTED TO ALL INTERESTED PERSONS SERVING THE ASSOCIATION AT THE TIME OF ANY SUCH ADOPTION OR AMENDMENT AND IN NO EVENT LESS OFTEN THAN ANNUALLY; AND TO ALL INDIVIDUALS SEEKING TO SERVE THE ASSOCIATION AS AN INTERESTED PERSON PRIOR TO REQUESTING ANY SUCH INDIVIDUAL TO EXECUTE A CONFLICT OF INTEREST DISCLOSURE STATEMENT. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION COMPENSATION IS ESTABLISHED FOR THE CEO BY THE COMPENSATION COMMITTEE AND THE EXECUTIVE COMMITTEE AFTER A THOROUGH SALARY/MARKET REVIEW CONDUCTED BY OUTSIDE COMPENSATION CONSULTANTS. FOR THE CEO POSITION, THE GATHERING OF RELEVANT COMPARABILITY DATA FROM INDEPENDENT SOURCES OCCURRED IN 2022. THE PROCESS WAS CONDUCTED IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER THE INTERMEDIATE SANCTIONS RULES. AS TO THE MEMBERS OF THE SENIOR MANAGEMENT TEAM OTHER THAN THE CEO, ANNUALLY UPDATED MARKET DATA IS ALSO PROVIDED BY THE OUTSIDE COMPENSATION CONSULTANT, SO THAT THE UPDATED MARKET DATA CAN BE USED IN SETTING REASONABLE COMPENSATION FOR EACH MEMBER OF THE SENIOR MANAGEMENT TEAM. EACH YEAR THE COMPENSATION COMMITTEE EVALUATES THE CEO'S PERFORMANCE THROUGH A ROBUST ASSESSMENT PROCESS WHICH INCLUDES COLLECTION, INTERVIEWS AND PERFORMANCE EVALUATION COMPARING RESULTS TO GOALS. THE COMMITTEE AND CHAIR OF THE BOARD USE THIS DATA TO DETERMINE INCENTIVE COMPENSATION ELIGIBILITY. THE SENIOR STAFF HAS A COMPREHENSIVE PERFORMANCE EVALUATION AND COMPENSATION REVIEW DONE AT THE END OF EACH FISCAL YEAR. THESE INCLUDE A SELF-ASSESSMENT AND EVALUATION BY THE CEO. UPDATED MARKET DATA FOR USE IN SETTING REASONABLE COMPENSATION IS PROVIDED BY A NATIONAL COMPENSATION CONSULTING FIRM TO THE COMPENSATION COMMITTEE FOR CONFIRMATION OF REASONABLENESS USING A PROCESS DESIGNED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS (INCLUDING CONTEMPORANEOUS DOCUMENTATION IN THE COMMITTEE'S MINUTES). COMPENSATION IS CONTEMPORANEOUSLY DOCUMENTED IN THE COMPENSATION COMMITTEE MINUTES. THE MOST RECENT COMPENSATION STUDY WAS CONDUCTED IN 2022 AND THE SALARY AND TOTALCOMPENSATION PACKAGE OF THE CEO WAS BENCHMARKED BY SULLIVAN COTTER. FORM 990, PART VI, SECTION C, LINE 18 HOW TAX FORMS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION MAKES ITS FORM 990 AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS FORM 1023 AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION'S AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE ORGANIZATION'S WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF PERPETUAL TRUSTS -3,640,879. CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS -801,308. BAD DEBT EXPENSE -1,581,293. RESCINDED GRANTS 1,528,961. ALZHEIMER'S IMPACT MOVEMENT (AIM) 225 N MICHIGAN AVE FL 17 CHICAGO IL 60601 271961435 SOCIAL WELFARE IL 501(C)(4) ALZ ASSOC 1 ALZHEIMER'S ASSOCIATION INTERNATIONAL 181 BAY ST BROOKFIELD PL 2100 TORONTO ONTARIO CA M5J2T3 999999999 PUBLIC FOUNDATION CA 501(C)(3) ALZ ASSOC 1 COALITION OF NY STATE ALZ ASSN CHAPS INC 4 PINE WEST PLAZA 405 ALBANY NY 12205 134076596 PUBLIC CHARITY NY 501(C)(3) LINE 7 ALZ ASSOC 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 ALZHEIMER'S IMPACT MOVEMENT B 10008054 FMV ALZHEIMER'S IMPACT MOVEMENT N 1088465 FMV ALZHEIMER'S IMPACT MOVEMENT O 4635172 FMV COALITION OF NY STATE ALZ ASSN CHAPS INC O 120484 FMV PART V, LINE 2: AMOUNT INVOLVED IN RELATIONSHIP THE ALZHEIMER'S ASSOCIATION GRANTED FUNDS TO ALZHEIMER'S IMPACT MOVEMENT (AIM) FOR PUBLIC POLICY DIVISION ACTIVITIES IN FISCAL YEAR 2022 TO SUPPORT PRIORITIES IDENTIFIED IN THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN. THIS GRANT IS RESTRICTED TO THE FOLLOWING 501(C)(3) ACTIVITIES AND THE ANCILLARY ACTIVITIES NECESSARY TO ACCOMPLISH SPECIFIC GOALS INCLUDING: IMPLEMENTATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (RECOGNIZING THIS GROWING ALZHEIMER'S CRISIS, CONGRESS UNANIMOUSLY PASSED AND THE PRESIDENT SIGNED INTO LAW THE NATIONAL ALZHEIMER'S PROJECT ACT - NAPA); INCREASING THE COMMITMENT TO ALZHEIMER'S RESEARCH; EXPANDING EDUCATION EFFORTS AND CAREGIVER SUPPORT SERVICES; EXPANDING DIAGNOSIS AND PLANNING.